AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
142.4|148.9|145.6|7899|All ICCC Groups Combined|54370170|0-14|All Races|Male and Female|1999|||
44.1|47.8|45.9|2494|I Leukemias, myeloproliferative & myelodysplastic diseases|54370170|0-14|All Races|Male and Female|1999|||
34.6|37.8|36.2|1965|I(a) Lymphoid leukemias|54370170|0-14|All Races|Male and Female|1999|||
6.9|8.4|7.6|414|I(b) Acute myeloid leukemias|54370170|0-14|All Races|Male and Female|1999|||
0.4|0.9|0.6|33|I(c) Chronic myeloproliferative diseases|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|54370170|0-14|All Races|Male and Female|1999|||
1.0|1.7|1.3|72|I(e) Unspecified and other specified leukemias|54370170|0-14|All Races|Male and Female|1999|||
14.4|16.5|15.4|836|II Lymphomas and reticuloendothelial neoplasms|54370170|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|297|II(a) Hodgkin lymphomas|54370170|0-14|All Races|Male and Female|1999|||
5.4|6.8|6.1|330|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|54370170|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|136|II(c) Burkitt lymphoma|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|52|II(d) Miscellaneous lymphoreticular neoplasms|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|21|II(e) Unspecified lymphomas|54370170|0-14|All Races|Male and Female|1999|||
29.6|32.6|31.1|1691|III CNS and misc intracranial and intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
2.4|3.3|2.8|154|III(a) Ependymomas and choroid plexus tumor|54370170|0-14|All Races|Male and Female|1999|||
12.9|14.9|13.9|754|III(b) Astrocytomas|54370170|0-14|All Races|Male and Female|1999|||
7.2|8.7|8.0|433|III(c) Intracranial and intraspinal embryonal tumors|54370170|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.2|284|III(d) Other gliomas|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|III(e) Other specified intracranial & intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|38|III(f) Unspecified intracranial and intraspinal neoplasms|54370170|0-14|All Races|Male and Female|1999|||
9.7|11.4|10.5|566|IV Neuroblastoma and other peripheral nervous cell tumors|54370170|0-14|All Races|Male and Female|1999|||
9.5|11.3|10.4|558|IV(a) Neuroblastoma and ganglioneuroblastoma|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|54370170|0-14|All Races|Male and Female|1999|||
8.6|10.2|9.4|509|IX Soft tissue and other extraosseous sarcomas|54370170|0-14|All Races|Male and Female|1999|||
4.3|5.5|4.8|263|IX(a) Rhabdomyosarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|54370170|0-14|All Races|Male and Female|1999|||
2.2|3.1|2.6|141|IX(d) Other specified soft tissue sarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|51|IX(e) Unspecified soft tissue sarcomas|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|Not classified by ICCC|54370170|0-14|All Races|Male and Female|1999|||
3.7|4.9|4.3|230|V Retinoblastoma|54370170|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|435|VI Renal tumors|54370170|0-14|All Races|Male and Female|1999|||
6.9|8.3|7.6|410|VI(a) Nephroblastoma and other nonepithelial renal tumors|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|22|VI(b) Renal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|54370170|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|114|VII Hepatic tumors|54370170|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|92|VII(a) Hepatoblastoma|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|22|VII(b) Hepatic carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|54370170|0-14|All Races|Male and Female|1999|||
6.5|8.0|7.2|391|VIII Malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|230|VIII(a) Osteosarcomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|54370170|0-14|All Races|Male and Female|1999|||
1.9|2.8|2.3|127|VIII(c) Ewing tumor and related sarcomas of bone|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|54370170|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|270|X Germ cell, trophoblastic tumors & neoplasms of gonads|54370170|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|73|X(a) Intracranial & intraspinal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|73|X(b) Malignant extracranial & extragonadal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|112|X(c) Malignant gonadal germ cell tumors|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|54370170|0-14|All Races|Male and Female|1999|||
5.2|6.6|5.9|318|XI Other malignant epithelial neoplasms and malignant melanomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.5|2.3|1.9|101|XI(b) Thyroid carcinomas|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|21|XI(c) Nasopharyngeal carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.4|2.2|1.8|96|XI(d) Malignant melanomas|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|54370170|0-14|All Races|Male and Female|1999|||
1.3|2.0|1.6|86|XI(f) Other and unspecified carcinomas|54370170|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|XII Other and unspecified malignant neoplasms|54370170|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|54370170|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|54370170|0-14|All Races|Male and Female|1999|||
145.4|151.9|148.6|8100|All ICCC Groups Combined|54640710|0-14|All Races|Male and Female|2000|||
44.2|47.8|46.0|2501|I Leukemias, myeloproliferative & myelodysplastic diseases|54640710|0-14|All Races|Male and Female|2000|||
35.6|38.8|37.2|2021|I(a) Lymphoid leukemias|54640710|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|359|I(b) Acute myeloid leukemias|54640710|0-14|All Races|Male and Female|2000|||
0.6|1.0|0.8|42|I(c) Chronic myeloproliferative diseases|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|54640710|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|70|I(e) Unspecified and other specified leukemias|54640710|0-14|All Races|Male and Female|2000|||
15.4|17.6|16.5|903|II Lymphomas and reticuloendothelial neoplasms|54640710|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|325|II(a) Hodgkin lymphomas|54640710|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|323|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|54640710|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|148|II(c) Burkitt lymphoma|54640710|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|70|II(d) Miscellaneous lymphoreticular neoplasms|54640710|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|37|II(e) Unspecified lymphomas|54640710|0-14|All Races|Male and Female|2000|||
31.1|34.1|32.6|1778|III CNS and misc intracranial and intraspinal neoplasms|54640710|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|147|III(a) Ependymomas and choroid plexus tumor|54640710|0-14|All Races|Male and Female|2000|||
15.6|17.8|16.7|910|III(b) Astrocytomas|54640710|0-14|All Races|Male and Female|2000|||
6.8|8.3|7.6|412|III(c) Intracranial and intraspinal embryonal tumors|54640710|0-14|All Races|Male and Female|2000|||
4.0|5.1|4.5|247|III(d) Other gliomas|54640710|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|25|III(e) Other specified intracranial & intraspinal neoplasms|54640710|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|37|III(f) Unspecified intracranial and intraspinal neoplasms|54640710|0-14|All Races|Male and Female|2000|||
9.2|10.9|10.0|541|IV Neuroblastoma and other peripheral nervous cell tumors|54640710|0-14|All Races|Male and Female|2000|||
9.0|10.7|9.9|534|IV(a) Neuroblastoma and ganglioneuroblastoma|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|54640710|0-14|All Races|Male and Female|2000|||
9.5|11.3|10.4|566|IX Soft tissue and other extraosseous sarcomas|54640710|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|286|IX(a) Rhabdomyosarcomas|54640710|0-14|All Races|Male and Female|2000|||
0.7|1.3|1.0|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|54640710|0-14|All Races|Male and Female|2000|||
2.7|3.6|3.1|170|IX(d) Other specified soft tissue sarcomas|54640710|0-14|All Races|Male and Female|2000|||
0.8|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|54640710|0-14|All Races|Male and Female|2000|||
3.8|4.9|4.3|234|V Retinoblastoma|54640710|0-14|All Races|Male and Female|2000|||
8.0|9.6|8.8|475|VI Renal tumors|54640710|0-14|All Races|Male and Female|2000|||
7.6|9.2|8.4|455|VI(a) Nephroblastoma and other nonepithelial renal tumors|54640710|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|54640710|0-14|All Races|Male and Female|2000|||
1.9|2.7|2.2|121|VII Hepatic tumors|54640710|0-14|All Races|Male and Female|2000|||
1.6|2.4|2.0|108|VII(a) Hepatoblastoma|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|54640710|0-14|All Races|Male and Female|2000|||
6.0|7.4|6.6|365|VIII Malignant bone tumors|54640710|0-14|All Races|Male and Female|2000|||
3.2|4.2|3.7|202|VIII(a) Osteosarcomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|54640710|0-14|All Races|Male and Female|2000|||
2.2|3.1|2.7|146|VIII(c) Ewing tumor and related sarcomas of bone|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|54640710|0-14|All Races|Male and Female|2000|||
4.3|5.5|4.8|264|X Germ cell, trophoblastic tumors & neoplasms of gonads|54640710|0-14|All Races|Male and Female|2000|||
1.2|1.8|1.5|80|X(a) Intracranial & intraspinal germ cell tumors|54640710|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|59|X(b) Malignant extracranial & extragonadal germ cell tumors|54640710|0-14|All Races|Male and Female|2000|||
1.7|2.5|2.1|114|X(c) Malignant gonadal germ cell tumors|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|54640710|0-14|All Races|Male and Female|2000|||
5.0|6.2|5.6|306|XI Other malignant epithelial neoplasms and malignant melanomas|54640710|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|54640710|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|101|XI(b) Thyroid carcinomas|54640710|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|54640710|0-14|All Races|Male and Female|2000|||
1.3|2.0|1.6|89|XI(d) Malignant melanomas|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|54640710|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|78|XI(f) Other and unspecified carcinomas|54640710|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|34|XII Other and unspecified malignant neoplasms|54640710|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|54640710|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|21|XII(b) Other unspecified malignant tumors|54640710|0-14|All Races|Male and Female|2000|||
152.0|158.5|155.2|8876|All ICCC Groups Combined|57196067|0-14|All Races|Male and Female|2001|||
48.7|52.4|50.5|2875|I Leukemias, myeloproliferative & myelodysplastic diseases|57196067|0-14|All Races|Male and Female|2001|||
37.2|40.5|38.9|2206|I(a) Lymphoid leukemias|57196067|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|419|I(b) Acute myeloid leukemias|57196067|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|93|I(c) Chronic myeloproliferative diseases|57196067|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57196067|0-14|All Races|Male and Female|2001|||
0.9|1.4|1.1|64|I(e) Unspecified and other specified leukemias|57196067|0-14|All Races|Male and Female|2001|||
15.0|17.1|16.0|919|II Lymphomas and reticuloendothelial neoplasms|57196067|0-14|All Races|Male and Female|2001|||
5.3|6.5|5.9|338|II(a) Hodgkin lymphomas|57196067|0-14|All Races|Male and Female|2001|||
5.9|7.3|6.6|376|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57196067|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.2|128|II(c) Burkitt lymphoma|57196067|0-14|All Races|Male and Female|2001|||
0.7|1.3|1.0|57|II(d) Miscellaneous lymphoreticular neoplasms|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|II(e) Unspecified lymphomas|57196067|0-14|All Races|Male and Female|2001|||
30.8|33.8|32.3|1843|III CNS and misc intracranial and intraspinal neoplasms|57196067|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.7|157|III(a) Ependymomas and choroid plexus tumor|57196067|0-14|All Races|Male and Female|2001|||
14.9|17.0|15.9|909|III(b) Astrocytomas|57196067|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.2|413|III(c) Intracranial and intraspinal embryonal tumors|57196067|0-14|All Races|Male and Female|2001|||
4.8|6.0|5.4|306|III(d) Other gliomas|57196067|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.6|37|III(e) Other specified intracranial & intraspinal neoplasms|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|21|III(f) Unspecified intracranial and intraspinal neoplasms|57196067|0-14|All Races|Male and Female|2001|||
10.8|12.6|11.7|669|IV Neuroblastoma and other peripheral nervous cell tumors|57196067|0-14|All Races|Male and Female|2001|||
10.7|12.5|11.6|663|IV(a) Neuroblastoma and ganglioneuroblastoma|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|57196067|0-14|All Races|Male and Female|2001|||
9.5|11.2|10.3|592|IX Soft tissue and other extraosseous sarcomas|57196067|0-14|All Races|Male and Female|2001|||
4.5|5.7|5.1|290|IX(a) Rhabdomyosarcomas|57196067|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|57196067|0-14|All Races|Male and Female|2001|||
2.6|3.5|3.0|172|IX(d) Other specified soft tissue sarcomas|57196067|0-14|All Races|Male and Female|2001|||
0.7|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.4|0.3|16|Not classified by ICCC|57196067|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.4|252|V Retinoblastoma|57196067|0-14|All Races|Male and Female|2001|||
7.8|9.3|8.6|486|VI Renal tumors|57196067|0-14|All Races|Male and Female|2001|||
7.4|8.9|8.2|464|VI(a) Nephroblastoma and other nonepithelial renal tumors|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|57196067|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|VII Hepatic tumors|57196067|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|96|VII(a) Hepatoblastoma|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57196067|0-14|All Races|Male and Female|2001|||
6.2|7.5|6.8|394|VIII Malignant bone tumors|57196067|0-14|All Races|Male and Female|2001|||
3.2|4.2|3.7|214|VIII(a) Osteosarcomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|57196067|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.7|155|VIII(c) Ewing tumor and related sarcomas of bone|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|57196067|0-14|All Races|Male and Female|2001|||
4.5|5.7|5.0|292|X Germ cell, trophoblastic tumors & neoplasms of gonads|57196067|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|57196067|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|81|X(b) Malignant extracranial & extragonadal germ cell tumors|57196067|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|X(c) Malignant gonadal germ cell tumors|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57196067|0-14|All Races|Male and Female|2001|||
6.1|7.4|6.7|387|XI Other malignant epithelial neoplasms and malignant melanomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(a) Adrenocortical carcinomas|57196067|0-14|All Races|Male and Female|2001|||
2.0|2.8|2.4|137|XI(b) Thyroid carcinomas|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|57196067|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|116|XI(d) Malignant melanomas|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|57196067|0-14|All Races|Male and Female|2001|||
1.4|2.1|1.7|97|XI(f) Other and unspecified carcinomas|57196067|0-14|All Races|Male and Female|2001|||
0.4|0.8|0.6|32|XII Other and unspecified malignant neoplasms|57196067|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|57196067|0-14|All Races|Male and Female|2001|||
~|~|~|~|XII(b) Other unspecified malignant tumors|57196067|0-14|All Races|Male and Female|2001|||
150.8|157.2|154.0|8816|All ICCC Groups Combined|57215071|0-14|All Races|Male and Female|2002|||
47.4|51.0|49.2|2807|I Leukemias, myeloproliferative & myelodysplastic diseases|57215071|0-14|All Races|Male and Female|2002|||
35.2|38.4|36.8|2094|I(a) Lymphoid leukemias|57215071|0-14|All Races|Male and Female|2002|||
7.2|8.6|7.9|453|I(b) Acute myeloid leukemias|57215071|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|91|I(c) Chronic myeloproliferative diseases|57215071|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57215071|0-14|All Races|Male and Female|2002|||
1.1|1.7|1.3|77|I(e) Unspecified and other specified leukemias|57215071|0-14|All Races|Male and Female|2002|||
14.5|16.6|15.5|893|II Lymphomas and reticuloendothelial neoplasms|57215071|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.3|310|II(a) Hodgkin lymphomas|57215071|0-14|All Races|Male and Female|2002|||
5.5|6.8|6.1|352|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57215071|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.7|156|II(c) Burkitt lymphoma|57215071|0-14|All Races|Male and Female|2002|||
0.8|1.4|1.1|63|II(d) Miscellaneous lymphoreticular neoplasms|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|57215071|0-14|All Races|Male and Female|2002|||
32.4|35.4|33.9|1933|III CNS and misc intracranial and intraspinal neoplasms|57215071|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.6|208|III(a) Ependymomas and choroid plexus tumor|57215071|0-14|All Races|Male and Female|2002|||
14.8|16.9|15.8|904|III(b) Astrocytomas|57215071|0-14|All Races|Male and Female|2002|||
6.7|8.2|7.4|423|III(c) Intracranial and intraspinal embryonal tumors|57215071|0-14|All Races|Male and Female|2002|||
5.2|6.5|5.8|333|III(d) Other gliomas|57215071|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|57215071|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|57215071|0-14|All Races|Male and Female|2002|||
10.0|11.7|10.8|621|IV Neuroblastoma and other peripheral nervous cell tumors|57215071|0-14|All Races|Male and Female|2002|||
9.9|11.6|10.7|615|IV(a) Neuroblastoma and ganglioneuroblastoma|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|57215071|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|626|IX Soft tissue and other extraosseous sarcomas|57215071|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.4|308|IX(a) Rhabdomyosarcomas|57215071|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|57215071|0-14|All Races|Male and Female|2002|||
2.9|3.9|3.4|195|IX(d) Other specified soft tissue sarcomas|57215071|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|57215071|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|23|Not classified by ICCC|57215071|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|213|V Retinoblastoma|57215071|0-14|All Races|Male and Female|2002|||
7.5|9.0|8.2|468|VI Renal tumors|57215071|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.0|455|VI(a) Nephroblastoma and other nonepithelial renal tumors|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|57215071|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|110|VII Hepatic tumors|57215071|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|90|VII(a) Hepatoblastoma|57215071|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57215071|0-14|All Races|Male and Female|2002|||
6.3|7.6|6.9|400|VIII Malignant bone tumors|57215071|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.7|216|VIII(a) Osteosarcomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|57215071|0-14|All Races|Male and Female|2002|||
2.2|3.0|2.6|148|VIII(c) Ewing tumor and related sarcomas of bone|57215071|0-14|All Races|Male and Female|2002|||
0.2|0.6|0.4|21|VIII(d) Other specified malignant bone tumors|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|57215071|0-14|All Races|Male and Female|2002|||
4.8|6.1|5.4|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|57215071|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|57215071|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|87|X(b) Malignant extracranial & extragonadal germ cell tumors|57215071|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.3|132|X(c) Malignant gonadal germ cell tumors|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57215071|0-14|All Races|Male and Female|2002|||
5.9|7.2|6.5|376|XI Other malignant epithelial neoplasms and malignant melanomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|57215071|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|112|XI(b) Thyroid carcinomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|57215071|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.3|131|XI(d) Malignant melanomas|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|57215071|0-14|All Races|Male and Female|2002|||
1.4|2.1|1.7|99|XI(f) Other and unspecified carcinomas|57215071|0-14|All Races|Male and Female|2002|||
0.4|0.8|0.6|32|XII Other and unspecified malignant neoplasms|57215071|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|57215071|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|57215071|0-14|All Races|Male and Female|2002|||
147.8|154.0|150.9|9011|All ICCC Groups Combined|59503617|0-14|All Races|Male and Female|2003|||
45.5|49.1|47.3|2813|I Leukemias, myeloproliferative & myelodysplastic diseases|59503617|0-14|All Races|Male and Female|2003|||
34.3|37.4|35.8|2127|I(a) Lymphoid leukemias|59503617|0-14|All Races|Male and Female|2003|||
6.7|8.1|7.4|444|I(b) Acute myeloid leukemias|59503617|0-14|All Races|Male and Female|2003|||
1.1|1.7|1.3|80|I(c) Chronic myeloproliferative diseases|59503617|0-14|All Races|Male and Female|2003|||
1.4|2.1|1.8|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59503617|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|56|I(e) Unspecified and other specified leukemias|59503617|0-14|All Races|Male and Female|2003|||
14.8|16.8|15.8|943|II Lymphomas and reticuloendothelial neoplasms|59503617|0-14|All Races|Male and Female|2003|||
5.2|6.5|5.8|350|II(a) Hodgkin lymphomas|59503617|0-14|All Races|Male and Female|2003|||
5.6|6.9|6.2|369|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59503617|0-14|All Races|Male and Female|2003|||
2.3|3.1|2.7|157|II(c) Burkitt lymphoma|59503617|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|60|II(d) Miscellaneous lymphoreticular neoplasms|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|59503617|0-14|All Races|Male and Female|2003|||
31.1|34.0|32.5|1932|III CNS and misc intracranial and intraspinal neoplasms|59503617|0-14|All Races|Male and Female|2003|||
2.1|3.0|2.5|151|III(a) Ependymomas and choroid plexus tumor|59503617|0-14|All Races|Male and Female|2003|||
15.0|17.1|16.0|953|III(b) Astrocytomas|59503617|0-14|All Races|Male and Female|2003|||
6.5|7.9|7.2|426|III(c) Intracranial and intraspinal embryonal tumors|59503617|0-14|All Races|Male and Female|2003|||
5.0|6.3|5.6|334|III(d) Other gliomas|59503617|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.8|48|III(e) Other specified intracranial & intraspinal neoplasms|59503617|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|III(f) Unspecified intracranial and intraspinal neoplasms|59503617|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|635|IV Neuroblastoma and other peripheral nervous cell tumors|59503617|0-14|All Races|Male and Female|2003|||
9.6|11.2|10.4|626|IV(a) Neuroblastoma and ganglioneuroblastoma|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59503617|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|630|IX Soft tissue and other extraosseous sarcomas|59503617|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|304|IX(a) Rhabdomyosarcomas|59503617|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|60|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|59503617|0-14|All Races|Male and Female|2003|||
3.0|3.9|3.4|206|IX(d) Other specified soft tissue sarcomas|59503617|0-14|All Races|Male and Female|2003|||
0.7|1.2|1.0|58|IX(e) Unspecified soft tissue sarcomas|59503617|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|16|Not classified by ICCC|59503617|0-14|All Races|Male and Female|2003|||
3.4|4.5|3.9|237|V Retinoblastoma|59503617|0-14|All Races|Male and Female|2003|||
7.7|9.2|8.5|505|VI Renal tumors|59503617|0-14|All Races|Male and Female|2003|||
7.4|8.8|8.1|481|VI(a) Nephroblastoma and other nonepithelial renal tumors|59503617|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59503617|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|150|VII Hepatic tumors|59503617|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|123|VII(a) Hepatoblastoma|59503617|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.4|27|VII(b) Hepatic carcinomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59503617|0-14|All Races|Male and Female|2003|||
6.1|7.5|6.8|407|VIII Malignant bone tumors|59503617|0-14|All Races|Male and Female|2003|||
3.3|4.3|3.8|228|VIII(a) Osteosarcomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|59503617|0-14|All Races|Male and Female|2003|||
1.9|2.7|2.3|135|VIII(c) Ewing tumor and related sarcomas of bone|59503617|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|17|VIII(d) Other specified malignant bone tumors|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59503617|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|308|X Germ cell, trophoblastic tumors & neoplasms of gonads|59503617|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|71|X(a) Intracranial & intraspinal germ cell tumors|59503617|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|88|X(b) Malignant extracranial & extragonadal germ cell tumors|59503617|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|133|X(c) Malignant gonadal germ cell tumors|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59503617|0-14|All Races|Male and Female|2003|||
5.8|7.1|6.5|391|XI Other malignant epithelial neoplasms and malignant melanomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59503617|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|134|XI(b) Thyroid carcinomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59503617|0-14|All Races|Male and Female|2003|||
1.6|2.4|2.0|120|XI(d) Malignant melanomas|59503617|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|59503617|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|59503617|0-14|All Races|Male and Female|2003|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|59503617|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|59503617|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|59503617|0-14|All Races|Male and Female|2003|||
152.8|155.6|154.2|45861|All ICCC Groups Combined|294993192|0-14|All Races|Male and Female|2003-2007|||
48.3|49.9|49.1|14599|I Leukemias, myeloproliferative & myelodysplastic diseases|294993192|0-14|All Races|Male and Female|2003-2007|||
36.6|38.0|37.3|11081|I(a) Lymphoid leukemias|294993192|0-14|All Races|Male and Female|2003-2007|||
7.2|7.8|7.5|2246|I(b) Acute myeloid leukemias|294993192|0-14|All Races|Male and Female|2003-2007|||
1.3|1.6|1.4|425|I(c) Chronic myeloproliferative diseases|294993192|0-14|All Races|Male and Female|2003-2007|||
1.4|1.7|1.5|465|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|294993192|0-14|All Races|Male and Female|2003-2007|||
1.2|1.4|1.3|382|I(e) Unspecified and other specified leukemias|294993192|0-14|All Races|Male and Female|2003-2007|||
15.8|16.8|16.3|4798|II Lymphomas and reticuloendothelial neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
5.5|6.0|5.8|1691|II(a) Hodgkin lymphomas|294993192|0-14|All Races|Male and Female|2003-2007|||
6.3|6.9|6.6|1932|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|294993192|0-14|All Races|Male and Female|2003-2007|||
2.4|2.7|2.5|745|II(c) Burkitt lymphoma|294993192|0-14|All Races|Male and Female|2003-2007|||
1.1|1.3|1.2|367|II(d) Miscellaneous lymphoreticular neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
0.2|0.3|0.2|63|II(e) Unspecified lymphomas|294993192|0-14|All Races|Male and Female|2003-2007|||
32.1|33.5|32.8|9689|III CNS and misc intracranial and intraspinal neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
2.7|3.1|2.9|857|III(a) Ependymomas and choroid plexus tumor|294993192|0-14|All Races|Male and Female|2003-2007|||
15.4|16.3|15.9|4687|III(b) Astrocytomas|294993192|0-14|All Races|Male and Female|2003-2007|||
7.0|7.7|7.3|2177|III(c) Intracranial and intraspinal embryonal tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
5.2|5.8|5.5|1610|III(d) Other gliomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.6|0.8|0.7|203|III(e) Other specified intracranial & intraspinal neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
0.4|0.6|0.5|155|III(f) Unspecified intracranial and intraspinal neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
10.4|11.2|10.8|3289|IV Neuroblastoma and other peripheral nervous cell tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
10.3|11.0|10.7|3242|IV(a) Neuroblastoma and ganglioneuroblastoma|294993192|0-14|All Races|Male and Female|2003-2007|||
0.1|0.2|0.2|47|IV(b) Other peripheral nervous cell tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
10.1|10.9|10.5|3118|IX Soft tissue and other extraosseous sarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
4.8|5.4|5.1|1510|IX(a) Rhabdomyosarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
1.0|1.2|1.1|329|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|294993192|0-14|All Races|Male and Female|2003-2007|||
~|~|~|~|IX(c) Kaposi sarcoma|294993192|0-14|All Races|Male and Female|2003-2007|||
3.2|3.6|3.4|1007|IX(d) Other specified soft tissue sarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.8|1.0|0.9|263|IX(e) Unspecified soft tissue sarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.2|0.3|0.3|75|Not classified by ICCC|294993192|0-14|All Races|Male and Female|2003-2007|||
3.8|4.2|4.0|1218|V Retinoblastoma|294993192|0-14|All Races|Male and Female|2003-2007|||
7.9|8.5|8.2|2459|VI Renal tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
7.5|8.1|7.8|2341|VI(a) Nephroblastoma and other nonepithelial renal tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
0.3|0.4|0.4|105|VI(b) Renal carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
2.3|2.7|2.5|757|VII Hepatic tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
1.9|2.3|2.1|638|VII(a) Hepatoblastoma|294993192|0-14|All Races|Male and Female|2003-2007|||
0.3|0.4|0.4|107|VII(b) Hepatic carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
6.6|7.2|6.9|2020|VIII Malignant bone tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
3.6|4.1|3.9|1131|VIII(a) Osteosarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.1|0.2|0.2|55|VIII(b) Chondrosarcomas|294993192|0-14|All Races|Male and Female|2003-2007|||
2.2|2.5|2.4|694|VIII(c) Ewing tumor and related sarcomas of bone|294993192|0-14|All Races|Male and Female|2003-2007|||
0.2|0.4|0.3|85|VIII(d) Other specified malignant bone tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
0.1|0.2|0.2|55|VIII(e) Unspecified malignant bone tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
5.1|5.6|5.3|1591|X Germ cell, trophoblastic tumors & neoplasms of gonads|294993192|0-14|All Races|Male and Female|2003-2007|||
1.2|1.5|1.4|403|X(a) Intracranial & intraspinal germ cell tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
1.3|1.5|1.4|431|X(b) Malignant extracranial & extragonadal germ cell tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
2.1|2.5|2.3|685|X(c) Malignant gonadal germ cell tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
0.1|0.2|0.1|33|X(d) Gonadal carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.1|0.2|0.1|39|X(e) Other and unspecified malignant gonadal tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
6.6|7.3|6.9|2052|XI Other malignant epithelial neoplasms and malignant melanomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.2|0.3|0.2|62|XI(a) Adrenocortical carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
2.2|2.5|2.3|692|XI(b) Thyroid carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.2|0.3|0.3|83|XI(c) Nasopharyngeal carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
2.1|2.5|2.3|673|XI(d) Malignant melanomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.0|0.1|0.1|19|XI(e) Skin carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
1.6|1.9|1.8|523|XI(f) Other and unspecified carcinomas|294993192|0-14|All Races|Male and Female|2003-2007|||
0.6|0.8|0.7|196|XII Other and unspecified malignant neoplasms|294993192|0-14|All Races|Male and Female|2003-2007|||
0.3|0.4|0.3|99|XII(a) Other specified malignant tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
0.3|0.4|0.3|97|XII(b) Other unspecified malignant tumors|294993192|0-14|All Races|Male and Female|2003-2007|||
154.7|161.0|157.8|9649|All ICCC Groups Combined|60736931|0-14|All Races|Male and Female|2004|||
48.6|52.2|50.4|3075|I Leukemias, myeloproliferative & myelodysplastic diseases|60736931|0-14|All Races|Male and Female|2004|||
36.6|39.7|38.1|2322|I(a) Lymphoid leukemias|60736931|0-14|All Races|Male and Female|2004|||
7.3|8.7|7.9|487|I(b) Acute myeloid leukemias|60736931|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|89|I(c) Chronic myeloproliferative diseases|60736931|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60736931|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|85|I(e) Unspecified and other specified leukemias|60736931|0-14|All Races|Male and Female|2004|||
15.1|17.2|16.1|983|II Lymphomas and reticuloendothelial neoplasms|60736931|0-14|All Races|Male and Female|2004|||
4.8|5.9|5.3|326|II(a) Hodgkin lymphomas|60736931|0-14|All Races|Male and Female|2004|||
6.2|7.5|6.8|415|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60736931|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.4|147|II(c) Burkitt lymphoma|60736931|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|78|II(d) Miscellaneous lymphoreticular neoplasms|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|17|II(e) Unspecified lymphomas|60736931|0-14|All Races|Male and Female|2004|||
32.6|35.5|34.0|2066|III CNS and misc intracranial and intraspinal neoplasms|60736931|0-14|All Races|Male and Female|2004|||
2.6|3.5|3.0|184|III(a) Ependymomas and choroid plexus tumor|60736931|0-14|All Races|Male and Female|2004|||
15.6|17.7|16.6|1008|III(b) Astrocytomas|60736931|0-14|All Races|Male and Female|2004|||
7.0|8.4|7.7|467|III(c) Intracranial and intraspinal embryonal tumors|60736931|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|326|III(d) Other gliomas|60736931|0-14|All Races|Male and Female|2004|||
0.6|1.0|0.8|47|III(e) Other specified intracranial & intraspinal neoplasms|60736931|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|34|III(f) Unspecified intracranial and intraspinal neoplasms|60736931|0-14|All Races|Male and Female|2004|||
10.0|11.7|10.8|673|IV Neuroblastoma and other peripheral nervous cell tumors|60736931|0-14|All Races|Male and Female|2004|||
9.8|11.5|10.6|659|IV(a) Neuroblastoma and ganglioneuroblastoma|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60736931|0-14|All Races|Male and Female|2004|||
9.7|11.3|10.5|641|IX Soft tissue and other extraosseous sarcomas|60736931|0-14|All Races|Male and Female|2004|||
4.1|5.3|4.7|285|IX(a) Rhabdomyosarcomas|60736931|0-14|All Races|Male and Female|2004|||
0.9|1.5|1.2|74|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60736931|0-14|All Races|Male and Female|2004|||
3.1|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60736931|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|61|IX(e) Unspecified soft tissue sarcomas|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|Not classified by ICCC|60736931|0-14|All Races|Male and Female|2004|||
3.7|4.8|4.2|265|V Retinoblastoma|60736931|0-14|All Races|Male and Female|2004|||
7.4|8.8|8.1|494|VI Renal tumors|60736931|0-14|All Races|Male and Female|2004|||
7.0|8.4|7.7|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60736931|0-14|All Races|Male and Female|2004|||
2.2|3.1|2.6|163|VII Hepatic tumors|60736931|0-14|All Races|Male and Female|2004|||
1.9|2.7|2.3|143|VII(a) Hepatoblastoma|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60736931|0-14|All Races|Male and Female|2004|||
6.5|7.8|7.1|435|VIII Malignant bone tumors|60736931|0-14|All Races|Male and Female|2004|||
3.7|4.7|4.1|253|VIII(a) Osteosarcomas|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60736931|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60736931|0-14|All Races|Male and Female|2004|||
5.1|6.3|5.7|351|X Germ cell, trophoblastic tumors & neoplasms of gonads|60736931|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|98|X(a) Intracranial & intraspinal germ cell tumors|60736931|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60736931|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|151|X(c) Malignant gonadal germ cell tumors|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60736931|0-14|All Races|Male and Female|2004|||
6.6|8.0|7.3|445|XI Other malignant epithelial neoplasms and malignant melanomas|60736931|0-14|All Races|Male and Female|2004|||
0.1|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60736931|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.5|155|XI(b) Thyroid carcinomas|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60736931|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|154|XI(d) Malignant melanomas|60736931|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60736931|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|90|XI(f) Other and unspecified carcinomas|60736931|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|41|XII Other and unspecified malignant neoplasms|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60736931|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|60736931|0-14|All Races|Male and Female|2004|||
149.6|155.8|152.6|9337|All ICCC Groups Combined|60630500|0-14|All Races|Male and Female|2005|||
46.6|50.1|48.3|2957|I Leukemias, myeloproliferative & myelodysplastic diseases|60630500|0-14|All Races|Male and Female|2005|||
35.3|38.4|36.8|2252|I(a) Lymphoid leukemias|60630500|0-14|All Races|Male and Female|2005|||
6.5|7.9|7.2|441|I(b) Acute myeloid leukemias|60630500|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|85|I(c) Chronic myeloproliferative diseases|60630500|0-14|All Races|Male and Female|2005|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60630500|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60630500|0-14|All Races|Male and Female|2005|||
15.5|17.6|16.5|1003|II Lymphomas and reticuloendothelial neoplasms|60630500|0-14|All Races|Male and Female|2005|||
5.4|6.6|6.0|362|II(a) Hodgkin lymphomas|60630500|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60630500|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.5|153|II(c) Burkitt lymphoma|60630500|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|II(d) Miscellaneous lymphoreticular neoplasms|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60630500|0-14|All Races|Male and Female|2005|||
30.2|33.0|31.6|1916|III CNS and misc intracranial and intraspinal neoplasms|60630500|0-14|All Races|Male and Female|2005|||
2.7|3.6|3.2|194|III(a) Ependymomas and choroid plexus tumor|60630500|0-14|All Races|Male and Female|2005|||
14.7|16.7|15.7|952|III(b) Astrocytomas|60630500|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|415|III(c) Intracranial and intraspinal embryonal tumors|60630500|0-14|All Races|Male and Female|2005|||
4.3|5.4|4.8|292|III(d) Other gliomas|60630500|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60630500|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.4|27|III(f) Unspecified intracranial and intraspinal neoplasms|60630500|0-14|All Races|Male and Female|2005|||
10.7|12.4|11.5|721|IV Neuroblastoma and other peripheral nervous cell tumors|60630500|0-14|All Races|Male and Female|2005|||
10.5|12.2|11.4|711|IV(a) Neuroblastoma and ganglioneuroblastoma|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60630500|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|646|IX Soft tissue and other extraosseous sarcomas|60630500|0-14|All Races|Male and Female|2005|||
4.8|6.0|5.4|326|IX(a) Rhabdomyosarcomas|60630500|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60630500|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60630500|0-14|All Races|Male and Female|2005|||
0.6|1.0|0.8|47|IX(e) Unspecified soft tissue sarcomas|60630500|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|21|Not classified by ICCC|60630500|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|235|V Retinoblastoma|60630500|0-14|All Races|Male and Female|2005|||
7.3|8.7|8.0|495|VI Renal tumors|60630500|0-14|All Races|Male and Female|2005|||
6.9|8.3|7.6|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|60630500|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60630500|0-14|All Races|Male and Female|2005|||
1.9|2.7|2.3|144|VII Hepatic tumors|60630500|0-14|All Races|Male and Female|2005|||
1.5|2.2|1.8|114|VII(a) Hepatoblastoma|60630500|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60630500|0-14|All Races|Male and Female|2005|||
6.1|7.5|6.8|409|VIII Malignant bone tumors|60630500|0-14|All Races|Male and Female|2005|||
3.3|4.3|3.7|225|VIII(a) Osteosarcomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60630500|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60630500|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60630500|0-14|All Races|Male and Female|2005|||
4.8|6.0|5.4|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|60630500|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.3|81|X(a) Intracranial & intraspinal germ cell tumors|60630500|0-14|All Races|Male and Female|2005|||
1.3|1.9|1.6|99|X(b) Malignant extracranial & extragonadal germ cell tumors|60630500|0-14|All Races|Male and Female|2005|||
1.9|2.7|2.2|138|X(c) Malignant gonadal germ cell tumors|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60630500|0-14|All Races|Male and Female|2005|||
6.3|7.7|7.0|423|XI Other malignant epithelial neoplasms and malignant melanomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60630500|0-14|All Races|Male and Female|2005|||
1.8|2.5|2.1|130|XI(b) Thyroid carcinomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60630500|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.5|149|XI(d) Malignant melanomas|60630500|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60630500|0-14|All Races|Male and Female|2005|||
1.7|2.4|2.0|121|XI(f) Other and unspecified carcinomas|60630500|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.5|33|XII Other and unspecified malignant neoplasms|60630500|0-14|All Races|Male and Female|2005|||
0.1|0.4|0.3|16|XII(a) Other specified malignant tumors|60630500|0-14|All Races|Male and Female|2005|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|60630500|0-14|All Races|Male and Female|2005|||
151.0|157.3|154.1|9440|All ICCC Groups Combined|60652932|0-14|All Races|Male and Female|2006|||
48.2|51.7|49.9|3063|I Leukemias, myeloproliferative & myelodysplastic diseases|60652932|0-14|All Races|Male and Female|2006|||
36.3|39.4|37.8|2318|I(a) Lymphoid leukemias|60652932|0-14|All Races|Male and Female|2006|||
6.9|8.3|7.6|468|I(b) Acute myeloid leukemias|60652932|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|91|I(c) Chronic myeloproliferative diseases|60652932|0-14|All Races|Male and Female|2006|||
1.3|2.0|1.6|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60652932|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60652932|0-14|All Races|Male and Female|2006|||
15.5|17.6|16.5|995|II Lymphomas and reticuloendothelial neoplasms|60652932|0-14|All Races|Male and Female|2006|||
5.6|6.8|6.2|371|II(a) Hodgkin lymphomas|60652932|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.4|386|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60652932|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|145|II(c) Burkitt lymphoma|60652932|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|81|II(d) Miscellaneous lymphoreticular neoplasms|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60652932|0-14|All Races|Male and Female|2006|||
30.9|33.8|32.3|1966|III CNS and misc intracranial and intraspinal neoplasms|60652932|0-14|All Races|Male and Female|2006|||
2.6|3.4|3.0|183|III(a) Ependymomas and choroid plexus tumor|60652932|0-14|All Races|Male and Female|2006|||
14.3|16.3|15.3|931|III(b) Astrocytomas|60652932|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|460|III(c) Intracranial and intraspinal embryonal tumors|60652932|0-14|All Races|Male and Female|2006|||
4.7|5.9|5.3|318|III(d) Other gliomas|60652932|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60652932|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.7|43|III(f) Unspecified intracranial and intraspinal neoplasms|60652932|0-14|All Races|Male and Female|2006|||
9.1|10.7|9.9|622|IV Neuroblastoma and other peripheral nervous cell tumors|60652932|0-14|All Races|Male and Female|2006|||
9.0|10.6|9.8|617|IV(a) Neuroblastoma and ganglioneuroblastoma|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60652932|0-14|All Races|Male and Female|2006|||
9.7|11.3|10.4|637|IX Soft tissue and other extraosseous sarcomas|60652932|0-14|All Races|Male and Female|2006|||
4.3|5.4|4.9|296|IX(a) Rhabdomyosarcomas|60652932|0-14|All Races|Male and Female|2006|||
0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60652932|0-14|All Races|Male and Female|2006|||
3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|60652932|0-14|All Races|Male and Female|2006|||
0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60652932|0-14|All Races|Male and Female|2006|||
3.4|4.4|3.9|249|V Retinoblastoma|60652932|0-14|All Races|Male and Female|2006|||
7.4|8.8|8.0|500|VI Renal tumors|60652932|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.7|478|VI(a) Nephroblastoma and other nonepithelial renal tumors|60652932|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VI(b) Renal carcinomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60652932|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|163|VII Hepatic tumors|60652932|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|134|VII(a) Hepatoblastoma|60652932|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60652932|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|422|VIII Malignant bone tumors|60652932|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|243|VIII(a) Osteosarcomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60652932|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|141|VIII(c) Ewing tumor and related sarcomas of bone|60652932|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60652932|0-14|All Races|Male and Female|2006|||
4.5|5.6|5.0|310|X Germ cell, trophoblastic tumors & neoplasms of gonads|60652932|0-14|All Races|Male and Female|2006|||
1.0|1.5|1.2|74|X(a) Intracranial & intraspinal germ cell tumors|60652932|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|94|X(b) Malignant extracranial & extragonadal germ cell tumors|60652932|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|128|X(c) Malignant gonadal germ cell tumors|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60652932|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.5|454|XI Other malignant epithelial neoplasms and malignant melanomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60652932|0-14|All Races|Male and Female|2006|||
2.2|3.1|2.6|157|XI(b) Thyroid carcinomas|60652932|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60652932|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|152|XI(d) Malignant melanomas|60652932|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60652932|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|108|XI(f) Other and unspecified carcinomas|60652932|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.7|46|XII Other and unspecified malignant neoplasms|60652932|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60652932|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60652932|0-14|All Races|Male and Female|2006|||
152.2|158.5|155.3|9478|All ICCC Groups Combined|60306965|0-14|All Races|Male and Female|2007|||
47.8|51.3|49.5|3032|I Leukemias, myeloproliferative & myelodysplastic diseases|60306965|0-14|All Races|Male and Female|2007|||
36.5|39.6|38.0|2326|I(a) Lymphoid leukemias|60306965|0-14|All Races|Male and Female|2007|||
6.7|8.1|7.4|451|I(b) Acute myeloid leukemias|60306965|0-14|All Races|Male and Female|2007|||
1.2|1.8|1.5|92|I(c) Chronic myeloproliferative diseases|60306965|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|87|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60306965|0-14|All Races|Male and Female|2007|||
1.0|1.5|1.2|76|I(e) Unspecified and other specified leukemias|60306965|0-14|All Races|Male and Female|2007|||
15.3|17.4|16.3|975|II Lymphomas and reticuloendothelial neoplasms|60306965|0-14|All Races|Male and Female|2007|||
4.8|6.0|5.4|319|II(a) Hodgkin lymphomas|60306965|0-14|All Races|Male and Female|2007|||
6.2|7.6|6.9|411|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60306965|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|159|II(c) Burkitt lymphoma|60306965|0-14|All Races|Male and Female|2007|||
0.9|1.4|1.1|70|II(d) Miscellaneous lymphoreticular neoplasms|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|II(e) Unspecified lymphomas|60306965|0-14|All Races|Male and Female|2007|||
31.7|34.6|33.1|2006|III CNS and misc intracranial and intraspinal neoplasms|60306965|0-14|All Races|Male and Female|2007|||
2.3|3.2|2.7|167|III(a) Ependymomas and choroid plexus tumor|60306965|0-14|All Races|Male and Female|2007|||
14.5|16.5|15.5|935|III(b) Astrocytomas|60306965|0-14|All Races|Male and Female|2007|||
6.8|8.2|7.5|458|III(c) Intracranial and intraspinal embryonal tumors|60306965|0-14|All Races|Male and Female|2007|||
5.5|6.7|6.1|367|III(d) Other gliomas|60306965|0-14|All Races|Male and Female|2007|||
0.6|1.0|0.8|46|III(e) Other specified intracranial & intraspinal neoplasms|60306965|0-14|All Races|Male and Female|2007|||
0.4|0.8|0.5|33|III(f) Unspecified intracranial and intraspinal neoplasms|60306965|0-14|All Races|Male and Female|2007|||
10.3|12.0|11.1|704|IV Neuroblastoma and other peripheral nervous cell tumors|60306965|0-14|All Races|Male and Female|2007|||
10.2|11.8|11.0|695|IV(a) Neuroblastoma and ganglioneuroblastoma|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60306965|0-14|All Races|Male and Female|2007|||
9.9|11.5|10.7|648|IX Soft tissue and other extraosseous sarcomas|60306965|0-14|All Races|Male and Female|2007|||
5.0|6.2|5.5|338|IX(a) Rhabdomyosarcomas|60306965|0-14|All Races|Male and Female|2007|||
0.8|1.4|1.1|66|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60306965|0-14|All Races|Male and Female|2007|||
2.8|3.8|3.3|196|IX(d) Other specified soft tissue sarcomas|60306965|0-14|All Races|Male and Female|2007|||
0.6|1.0|0.8|47|IX(e) Unspecified soft tissue sarcomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60306965|0-14|All Races|Male and Female|2007|||
3.6|4.6|4.0|259|V Retinoblastoma|60306965|0-14|All Races|Male and Female|2007|||
7.6|9.0|8.3|515|VI Renal tumors|60306965|0-14|All Races|Male and Female|2007|||
7.2|8.6|7.8|488|VI(a) Nephroblastoma and other nonepithelial renal tumors|60306965|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60306965|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|158|VII Hepatic tumors|60306965|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|141|VII(a) Hepatoblastoma|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|17|VII(b) Hepatic carcinomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60306965|0-14|All Races|Male and Female|2007|||
6.1|7.5|6.8|401|VIII Malignant bone tumors|60306965|0-14|All Races|Male and Female|2007|||
3.1|4.1|3.6|211|VIII(a) Osteosarcomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60306965|0-14|All Races|Male and Female|2007|||
2.1|3.0|2.5|150|VIII(c) Ewing tumor and related sarcomas of bone|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|VIII(e) Unspecified malignant bone tumors|60306965|0-14|All Races|Male and Female|2007|||
4.8|6.0|5.4|329|X Germ cell, trophoblastic tumors & neoplasms of gonads|60306965|0-14|All Races|Male and Female|2007|||
1.1|1.8|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|60306965|0-14|All Races|Male and Female|2007|||
1.0|1.5|1.2|78|X(b) Malignant extracranial & extragonadal germ cell tumors|60306965|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|155|X(c) Malignant gonadal germ cell tumors|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60306965|0-14|All Races|Male and Female|2007|||
6.1|7.4|6.7|399|XI Other malignant epithelial neoplasms and malignant melanomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60306965|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|131|XI(b) Thyroid carcinomas|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|XI(c) Nasopharyngeal carcinomas|60306965|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|134|XI(d) Malignant melanomas|60306965|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60306965|0-14|All Races|Male and Female|2007|||
1.4|2.1|1.7|101|XI(f) Other and unspecified carcinomas|60306965|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.6|40|XII Other and unspecified malignant neoplasms|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60306965|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|60306965|0-14|All Races|Male and Female|2007|||
155.8|161.6|158.7|11490|All ICCC Groups Combined|72548146|0-19|All Races|Male and Female|1999|155.5|161.3|158.4
39.7|42.7|41.1|2983|I Leukemias, myeloproliferative & myelodysplastic diseases|72548146|0-19|All Races|Male and Female|1999|39.7|42.6|41.1
29.4|31.9|30.6|2223|I(a) Lymphoid leukemias|72548146|0-19|All Races|Male and Female|1999|29.4|31.9|30.6
7.4|8.8|8.1|585|I(b) Acute myeloid leukemias|72548146|0-19|All Races|Male and Female|1999|7.4|8.7|8.1
0.8|1.3|1.0|72|I(c) Chronic myeloproliferative diseases|72548146|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|72548146|0-19|All Races|Male and Female|1999|~|~|~
1.0|1.6|1.3|92|I(e) Unspecified and other specified leukemias|72548146|0-19|All Races|Male and Female|1999|1.0|1.6|1.3
22.2|24.4|23.3|1684|II Lymphomas and reticuloendothelial neoplasms|72548146|0-19|All Races|Male and Female|1999|22.1|24.3|23.2
11.0|12.6|11.8|855|II(a) Hodgkin lymphomas|72548146|0-19|All Races|Male and Female|1999|11.0|12.6|11.8
7.1|8.4|7.7|558|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|72548146|0-19|All Races|Male and Female|1999|7.1|8.4|7.7
2.1|2.8|2.4|176|II(c) Burkitt lymphoma|72548146|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.6|1.0|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|72548146|0-19|All Races|Male and Female|1999|0.6|1.0|0.7
0.4|0.8|0.6|41|II(e) Unspecified lymphomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
26.9|29.4|28.1|2043|III CNS and misc intracranial and intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|27.0|29.4|28.2
2.2|2.9|2.5|182|III(a) Ependymomas and choroid plexus tumor|72548146|0-19|All Races|Male and Female|1999|2.2|2.9|2.5
12.3|14.0|13.1|954|III(b) Astrocytomas|72548146|0-19|All Races|Male and Female|1999|12.3|14.0|13.1
6.1|7.3|6.7|486|III(c) Intracranial and intraspinal embryonal tumors|72548146|0-19|All Races|Male and Female|1999|6.1|7.3|6.7
4.2|5.2|4.7|340|III(d) Other gliomas|72548146|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.4|0.7|0.5|37|III(e) Other specified intracranial & intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.4|0.8|0.6|44|III(f) Unspecified intracranial and intraspinal neoplasms|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.5|8.8|8.2|587|IV Neuroblastoma and other peripheral nervous cell tumors|72548146|0-19|All Races|Male and Female|1999|7.4|8.8|8.1
7.2|8.5|7.9|566|IV(a) Neuroblastoma and ganglioneuroblastoma|72548146|0-19|All Races|Male and Female|1999|7.2|8.5|7.8
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|72548146|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.0|11.5|10.7|778|IX Soft tissue and other extraosseous sarcomas|72548146|0-19|All Races|Male and Female|1999|10.0|11.5|10.7
4.0|5.0|4.5|325|IX(a) Rhabdomyosarcomas|72548146|0-19|All Races|Male and Female|1999|4.0|5.0|4.5
0.9|1.4|1.1|82|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|72548146|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|72548146|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.3|3.9|279|IX(d) Other specified soft tissue sarcomas|72548146|0-19|All Races|Male and Female|1999|3.4|4.3|3.8
1.0|1.5|1.2|89|IX(e) Unspecified soft tissue sarcomas|72548146|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.5|0.3|23|Not classified by ICCC|72548146|0-19|All Races|Male and Female|1999|0.2|0.5|0.3
2.8|3.7|3.2|231|V Retinoblastoma|72548146|0-19|All Races|Male and Female|1999|2.8|3.6|3.2
5.8|7.0|6.4|461|VI Renal tumors|72548146|0-19|All Races|Male and Female|1999|5.8|7.0|6.4
5.2|6.4|5.8|418|VI(a) Nephroblastoma and other nonepithelial renal tumors|72548146|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|39|VI(b) Renal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.4|2.0|144|VII Hepatic tumors|72548146|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.0|1.6|1.3|92|VII(a) Hepatoblastoma|72548146|0-19|All Races|Male and Female|1999|1.0|1.6|1.3
0.5|0.9|0.7|51|VII(b) Hepatic carcinomas|72548146|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
8.2|9.6|8.9|641|VIII Malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|8.2|9.5|8.8
4.6|5.7|5.1|372|VIII(a) Osteosarcomas|72548146|0-19|All Races|Male and Female|1999|4.6|5.7|5.1
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|72548146|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.3|3.1|2.7|195|VIII(c) Ewing tumor and related sarcomas of bone|72548146|0-19|All Races|Male and Female|1999|2.3|3.1|2.7
0.3|0.7|0.5|36|VIII(d) Other specified malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|72548146|0-19|All Races|Male and Female|1999|~|~|~
9.5|11.0|10.2|739|X Germ cell, trophoblastic tumors & neoplasms of gonads|72548146|0-19|All Races|Male and Female|1999|9.5|10.9|10.2
1.2|1.7|1.4|103|X(a) Intracranial & intraspinal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|1.2|1.7|1.4
1.1|1.7|1.4|99|X(b) Malignant extracranial & extragonadal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
6.2|7.4|6.8|489|X(c) Malignant gonadal germ cell tumors|72548146|0-19|All Races|Male and Female|1999|6.2|7.4|6.7
0.3|0.6|0.4|30|X(d) Gonadal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|72548146|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.6|16.5|15.5|1122|XI Other malignant epithelial neoplasms and malignant melanomas|72548146|0-19|All Races|Male and Female|1999|14.6|16.4|15.5
~|~|~|~|XI(a) Adrenocortical carcinomas|72548146|0-19|All Races|Male and Female|1999|~|~|~
5.3|6.5|5.9|426|XI(b) Thyroid carcinomas|72548146|0-19|All Races|Male and Female|1999|5.3|6.5|5.9
0.4|0.8|0.6|41|XI(c) Nasopharyngeal carcinomas|72548146|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
4.3|5.3|4.8|346|XI(d) Malignant melanomas|72548146|0-19|All Races|Male and Female|1999|4.3|5.3|4.8
~|~|~|~|XI(e) Skin carcinomas|72548146|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.5|4.0|288|XI(f) Other and unspecified carcinomas|72548146|0-19|All Races|Male and Female|1999|3.5|4.5|4.0
0.6|1.0|0.7|54|XII Other and unspecified malignant neoplasms|72548146|0-19|All Races|Male and Female|1999|0.6|1.0|0.7
0.1|0.4|0.2|16|XII(a) Other specified malignant tumors|72548146|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
0.4|0.7|0.5|38|XII(b) Other unspecified malignant tumors|72548146|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
159.9|165.8|162.8|11862|All ICCC Groups Combined|72982608|0-19|All Races|Male and Female|2000|159.6|165.5|162.5
39.8|42.8|41.3|3003|I Leukemias, myeloproliferative & myelodysplastic diseases|72982608|0-19|All Races|Male and Female|2000|39.7|42.6|41.1
30.6|33.2|31.9|2316|I(a) Lymphoid leukemias|72982608|0-19|All Races|Male and Female|2000|30.5|33.1|31.7
6.5|7.7|7.1|517|I(b) Acute myeloid leukemias|72982608|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.1|0.9|66|I(c) Chronic myeloproliferative diseases|72982608|0-19|All Races|Male and Female|2000|0.7|1.2|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|72982608|0-19|All Races|Male and Female|2000|~|~|~
1.0|1.6|1.3|94|I(e) Unspecified and other specified leukemias|72982608|0-19|All Races|Male and Female|2000|1.0|1.6|1.3
23.6|25.9|24.7|1806|II Lymphomas and reticuloendothelial neoplasms|72982608|0-19|All Races|Male and Female|2000|23.6|25.9|24.7
11.5|13.1|12.3|898|II(a) Hodgkin lymphomas|72982608|0-19|All Races|Male and Female|2000|11.5|13.1|12.3
7.4|8.8|8.1|591|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|72982608|0-19|All Races|Male and Female|2000|7.5|8.8|8.1
2.3|3.0|2.6|192|II(c) Burkitt lymphoma|72982608|0-19|All Races|Male and Female|2000|2.3|3.0|2.6
0.8|1.3|1.0|73|II(d) Miscellaneous lymphoreticular neoplasms|72982608|0-19|All Races|Male and Female|2000|0.8|1.3|1.0
0.5|0.9|0.7|52|II(e) Unspecified lymphomas|72982608|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
28.5|31.1|29.8|2172|III CNS and misc intracranial and intraspinal neoplasms|72982608|0-19|All Races|Male and Female|2000|28.5|31.0|29.8
2.0|2.7|2.4|171|III(a) Ependymomas and choroid plexus tumor|72982608|0-19|All Races|Male and Female|2000|2.0|2.7|2.3
14.5|16.3|15.4|1125|III(b) Astrocytomas|72982608|0-19|All Races|Male and Female|2000|14.5|16.3|15.4
5.9|7.1|6.5|474|III(c) Intracranial and intraspinal embryonal tumors|72982608|0-19|All Races|Male and Female|2000|5.9|7.1|6.5
3.9|4.9|4.4|320|III(d) Other gliomas|72982608|0-19|All Races|Male and Female|2000|3.9|4.9|4.4
0.3|0.7|0.5|34|III(e) Other specified intracranial & intraspinal neoplasms|72982608|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
0.5|0.9|0.7|48|III(f) Unspecified intracranial and intraspinal neoplasms|72982608|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.0|8.2|7.6|549|IV Neuroblastoma and other peripheral nervous cell tumors|72982608|0-19|All Races|Male and Female|2000|6.9|8.2|7.5
6.8|8.1|7.5|540|IV(a) Neuroblastoma and ganglioneuroblastoma|72982608|0-19|All Races|Male and Female|2000|6.8|8.1|7.4
~|~|~|~|IV(b) Other peripheral nervous cell tumors|72982608|0-19|All Races|Male and Female|2000|~|~|~
11.1|12.7|11.9|867|IX Soft tissue and other extraosseous sarcomas|72982608|0-19|All Races|Male and Female|2000|11.1|12.7|11.9
4.4|5.4|4.8|353|IX(a) Rhabdomyosarcomas|72982608|0-19|All Races|Male and Female|2000|4.3|5.4|4.8
1.0|1.5|1.2|88|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|72982608|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|72982608|0-19|All Races|Male and Female|2000|~|~|~
4.0|4.9|4.4|323|IX(d) Other specified soft tissue sarcomas|72982608|0-19|All Races|Male and Female|2000|4.0|4.9|4.4
1.1|1.6|1.4|99|IX(e) Unspecified soft tissue sarcomas|72982608|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
~|~|~|~|Not classified by ICCC|72982608|0-19|All Races|Male and Female|2000|~|~|~
2.9|3.7|3.3|235|V Retinoblastoma|72982608|0-19|All Races|Male and Female|2000|2.8|3.7|3.2
6.2|7.4|6.8|494|VI Renal tumors|72982608|0-19|All Races|Male and Female|2000|6.2|7.4|6.8
5.8|6.9|6.3|459|VI(a) Nephroblastoma and other nonepithelial renal tumors|72982608|0-19|All Races|Male and Female|2000|5.7|6.9|6.3
0.3|0.6|0.5|34|VI(b) Renal carcinomas|72982608|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|72982608|0-19|All Races|Male and Female|2000|~|~|~
1.6|2.2|1.9|135|VII Hepatic tumors|72982608|0-19|All Races|Male and Female|2000|1.6|2.2|1.8
1.2|1.8|1.5|108|VII(a) Hepatoblastoma|72982608|0-19|All Races|Male and Female|2000|1.2|1.8|1.5
0.2|0.5|0.4|27|VII(b) Hepatic carcinomas|72982608|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|72982608|0-19|All Races|Male and Female|2000|~|~|~
7.9|9.2|8.5|624|VIII Malignant bone tumors|72982608|0-19|All Races|Male and Female|2000|7.9|9.2|8.5
4.3|5.4|4.8|354|VIII(a) Osteosarcomas|72982608|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
~|~|~|~|VIII(b) Chondrosarcomas|72982608|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|226|VIII(c) Ewing tumor and related sarcomas of bone|72982608|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|17|VIII(d) Other specified malignant bone tumors|72982608|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
~|~|~|~|VIII(e) Unspecified malignant bone tumors|72982608|0-19|All Races|Male and Female|2000|~|~|~
9.9|11.4|10.7|778|X Germ cell, trophoblastic tumors & neoplasms of gonads|72982608|0-19|All Races|Male and Female|2000|9.9|11.4|10.7
1.4|2.0|1.7|122|X(a) Intracranial & intraspinal germ cell tumors|72982608|0-19|All Races|Male and Female|2000|1.4|2.0|1.7
1.1|1.7|1.4|102|X(b) Malignant extracranial & extragonadal germ cell tumors|72982608|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.3|7.5|6.9|503|X(c) Malignant gonadal germ cell tumors|72982608|0-19|All Races|Male and Female|2000|6.3|7.5|6.9
0.3|0.7|0.5|35|X(d) Gonadal carcinomas|72982608|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
0.1|0.4|0.2|16|X(e) Other and unspecified malignant gonadal tumors|72982608|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.7|16.5|15.6|1136|XI Other malignant epithelial neoplasms and malignant melanomas|72982608|0-19|All Races|Male and Female|2000|14.7|16.5|15.6
0.2|0.5|0.3|24|XI(a) Adrenocortical carcinomas|72982608|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.7|414|XI(b) Thyroid carcinomas|72982608|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|37|XI(c) Nasopharyngeal carcinomas|72982608|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.5|5.6|5.0|368|XI(d) Malignant melanomas|72982608|0-19|All Races|Male and Female|2000|4.5|5.6|5.0
~|~|~|~|XI(e) Skin carcinomas|72982608|0-19|All Races|Male and Female|2000|~|~|~
3.5|4.4|3.9|287|XI(f) Other and unspecified carcinomas|72982608|0-19|All Races|Male and Female|2000|3.5|4.4|3.9
0.5|0.9|0.7|48|XII Other and unspecified malignant neoplasms|72982608|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
~|~|~|~|XII(a) Other specified malignant tumors|72982608|0-19|All Races|Male and Female|2000|~|~|~
0.3|0.6|0.5|33|XII(b) Other unspecified malignant tumors|72982608|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
166.6|172.5|169.5|12945|All ICCC Groups Combined|76387462|0-19|All Races|Male and Female|2001|166.6|172.4|169.5
44.1|47.2|45.6|3472|I Leukemias, myeloproliferative & myelodysplastic diseases|76387462|0-19|All Races|Male and Female|2001|44.0|47.0|45.5
31.9|34.5|33.2|2517|I(a) Lymphoid leukemias|76387462|0-19|All Races|Male and Female|2001|31.7|34.3|33.0
7.0|8.3|7.6|585|I(b) Acute myeloid leukemias|76387462|0-19|All Races|Male and Female|2001|7.1|8.3|7.7
1.8|2.5|2.1|162|I(c) Chronic myeloproliferative diseases|76387462|0-19|All Races|Male and Female|2001|1.8|2.5|2.1
1.3|1.8|1.5|116|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76387462|0-19|All Races|Male and Female|2001|1.3|1.8|1.5
1.0|1.5|1.2|92|I(e) Unspecified and other specified leukemias|76387462|0-19|All Races|Male and Female|2001|1.0|1.5|1.2
23.5|25.8|24.6|1884|II Lymphomas and reticuloendothelial neoplasms|76387462|0-19|All Races|Male and Female|2001|23.6|25.8|24.7
11.8|13.4|12.5|960|II(a) Hodgkin lymphomas|76387462|0-19|All Races|Male and Female|2001|11.8|13.4|12.6
8.1|9.4|8.7|668|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76387462|0-19|All Races|Male and Female|2001|8.1|9.4|8.7
1.8|2.5|2.2|164|II(c) Burkitt lymphoma|76387462|0-19|All Races|Male and Female|2001|1.8|2.5|2.1
0.6|1.0|0.8|59|II(d) Miscellaneous lymphoreticular neoplasms|76387462|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.3|0.6|0.4|33|II(e) Unspecified lymphomas|76387462|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
28.3|30.8|29.5|2252|III CNS and misc intracranial and intraspinal neoplasms|76387462|0-19|All Races|Male and Female|2001|28.3|30.7|29.5
2.1|2.8|2.4|184|III(a) Ependymomas and choroid plexus tumor|76387462|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
13.8|15.6|14.7|1120|III(b) Astrocytomas|76387462|0-19|All Races|Male and Female|2001|13.8|15.5|14.7
6.0|7.1|6.5|497|III(c) Intracranial and intraspinal embryonal tumors|76387462|0-19|All Races|Male and Female|2001|5.9|7.1|6.5
4.5|5.5|5.0|379|III(d) Other gliomas|76387462|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
0.4|0.8|0.6|44|III(e) Other specified intracranial & intraspinal neoplasms|76387462|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
0.2|0.5|0.4|28|III(f) Unspecified intracranial and intraspinal neoplasms|76387462|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
8.3|9.6|8.9|683|IV Neuroblastoma and other peripheral nervous cell tumors|76387462|0-19|All Races|Male and Female|2001|8.3|9.6|8.9
8.1|9.4|8.7|670|IV(a) Neuroblastoma and ganglioneuroblastoma|76387462|0-19|All Races|Male and Female|2001|8.1|9.5|8.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|76387462|0-19|All Races|Male and Female|2001|~|~|~
10.9|12.5|11.7|893|IX Soft tissue and other extraosseous sarcomas|76387462|0-19|All Races|Male and Female|2001|10.9|12.5|11.7
4.4|5.4|4.9|374|IX(a) Rhabdomyosarcomas|76387462|0-19|All Races|Male and Female|2001|4.4|5.4|4.9
1.2|1.8|1.5|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76387462|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|76387462|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|310|IX(d) Other specified soft tissue sarcomas|76387462|0-19|All Races|Male and Female|2001|3.6|4.5|4.1
1.0|1.5|1.2|94|IX(e) Unspecified soft tissue sarcomas|76387462|0-19|All Races|Male and Female|2001|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|76387462|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
2.9|3.7|3.3|252|V Retinoblastoma|76387462|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.2|7.3|6.7|511|VI Renal tumors|76387462|0-19|All Races|Male and Female|2001|6.1|7.3|6.7
5.6|6.7|6.2|467|VI(a) Nephroblastoma and other nonepithelial renal tumors|76387462|0-19|All Races|Male and Female|2001|5.6|6.7|6.1
0.4|0.7|0.5|42|VI(b) Renal carcinomas|76387462|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|76387462|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|138|VII Hepatic tumors|76387462|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|97|VII(a) Hepatoblastoma|76387462|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|40|VII(b) Hepatic carcinomas|76387462|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76387462|0-19|All Races|Male and Female|2001|~|~|~
8.7|10.1|9.4|719|VIII Malignant bone tumors|76387462|0-19|All Races|Male and Female|2001|8.7|10.1|9.4
4.6|5.6|5.1|392|VIII(a) Osteosarcomas|76387462|0-19|All Races|Male and Female|2001|4.6|5.7|5.1
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|76387462|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|259|VIII(c) Ewing tumor and related sarcomas of bone|76387462|0-19|All Races|Male and Female|2001|3.0|3.8|3.4
0.3|0.6|0.4|30|VIII(d) Other specified malignant bone tumors|76387462|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|76387462|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.2|10.4|801|X Germ cell, trophoblastic tumors & neoplasms of gonads|76387462|0-19|All Races|Male and Female|2001|9.8|11.2|10.5
1.3|1.9|1.6|121|X(a) Intracranial & intraspinal germ cell tumors|76387462|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|76387462|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.1|7.3|6.7|509|X(c) Malignant gonadal germ cell tumors|76387462|0-19|All Races|Male and Female|2001|6.1|7.3|6.7
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|76387462|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|76387462|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.6|17.5|16.5|1265|XI Other malignant epithelial neoplasms and malignant melanomas|76387462|0-19|All Races|Male and Female|2001|15.7|17.5|16.6
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|76387462|0-19|All Races|Male and Female|2001|0.1|0.3|0.2
5.3|6.4|5.8|447|XI(b) Thyroid carcinomas|76387462|0-19|All Races|Male and Female|2001|5.3|6.4|5.9
0.4|0.8|0.6|44|XI(c) Nasopharyngeal carcinomas|76387462|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
5.3|6.4|5.8|444|XI(d) Malignant melanomas|76387462|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
~|~|~|~|XI(e) Skin carcinomas|76387462|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.0|309|XI(f) Other and unspecified carcinomas|76387462|0-19|All Races|Male and Female|2001|3.6|4.5|4.0
0.5|0.9|0.7|53|XII Other and unspecified malignant neoplasms|76387462|0-19|All Races|Male and Female|2001|0.5|0.9|0.7
0.2|0.5|0.4|28|XII(a) Other specified malignant tumors|76387462|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
0.2|0.5|0.3|25|XII(b) Other unspecified malignant tumors|76387462|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
166.7|172.5|169.6|12964|All ICCC Groups Combined|76418439|0-19|All Races|Male and Female|2002|166.7|172.6|169.6
43.1|46.1|44.6|3403|I Leukemias, myeloproliferative & myelodysplastic diseases|76418439|0-19|All Races|Male and Female|2002|43.0|46.1|44.5
30.4|33.0|31.7|2410|I(a) Lymphoid leukemias|76418439|0-19|All Races|Male and Female|2002|30.3|32.8|31.5
7.6|8.9|8.2|628|I(b) Acute myeloid leukemias|76418439|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
1.7|2.4|2.0|155|I(c) Chronic myeloproliferative diseases|76418439|0-19|All Races|Male and Female|2002|1.7|2.4|2.0
1.2|1.8|1.5|115|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76418439|0-19|All Races|Male and Female|2002|1.2|1.8|1.5
1.0|1.5|1.2|95|I(e) Unspecified and other specified leukemias|76418439|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
23.2|25.4|24.3|1859|II Lymphomas and reticuloendothelial neoplasms|76418439|0-19|All Races|Male and Female|2002|23.2|25.5|24.3
11.4|13.0|12.2|934|II(a) Hodgkin lymphomas|76418439|0-19|All Races|Male and Female|2002|11.5|13.0|12.2
7.6|8.9|8.2|630|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76418439|0-19|All Races|Male and Female|2002|7.6|8.9|8.2
2.4|3.1|2.7|207|II(c) Burkitt lymphoma|76418439|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.6|1.1|0.8|64|II(d) Miscellaneous lymphoreticular neoplasms|76418439|0-19|All Races|Male and Female|2002|0.6|1.1|0.8
0.2|0.5|0.3|24|II(e) Unspecified lymphomas|76418439|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
29.5|32.0|30.8|2347|III CNS and misc intracranial and intraspinal neoplasms|76418439|0-19|All Races|Male and Female|2002|29.5|32.0|30.7
2.6|3.4|3.0|228|III(a) Ependymomas and choroid plexus tumor|76418439|0-19|All Races|Male and Female|2002|2.6|3.4|3.0
14.0|15.8|14.9|1134|III(b) Astrocytomas|76418439|0-19|All Races|Male and Female|2002|14.0|15.7|14.8
5.8|7.0|6.4|486|III(c) Intracranial and intraspinal embryonal tumors|76418439|0-19|All Races|Male and Female|2002|5.8|7.0|6.4
4.9|6.0|5.5|415|III(d) Other gliomas|76418439|0-19|All Races|Male and Female|2002|4.9|6.0|5.4
0.6|1.0|0.7|56|III(e) Other specified intracranial & intraspinal neoplasms|76418439|0-19|All Races|Male and Female|2002|0.6|1.0|0.7
0.2|0.5|0.4|28|III(f) Unspecified intracranial and intraspinal neoplasms|76418439|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
7.7|9.0|8.3|636|IV Neuroblastoma and other peripheral nervous cell tumors|76418439|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
7.5|8.7|8.1|620|IV(a) Neuroblastoma and ganglioneuroblastoma|76418439|0-19|All Races|Male and Female|2002|7.5|8.8|8.1
0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|76418439|0-19|All Races|Male and Female|2002|0.1|0.3|0.2
11.0|12.6|11.8|903|IX Soft tissue and other extraosseous sarcomas|76418439|0-19|All Races|Male and Female|2002|11.1|12.6|11.8
4.4|5.4|4.9|373|IX(a) Rhabdomyosarcomas|76418439|0-19|All Races|Male and Female|2002|4.4|5.4|4.9
1.0|1.5|1.2|92|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76418439|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|76418439|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.2|4.7|363|IX(d) Other specified soft tissue sarcomas|76418439|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|75|IX(e) Unspecified soft tissue sarcomas|76418439|0-19|All Races|Male and Female|2002|0.8|1.2|1.0
0.2|0.5|0.4|27|Not classified by ICCC|76418439|0-19|All Races|Male and Female|2002|0.2|0.5|0.4
2.4|3.2|2.8|213|V Retinoblastoma|76418439|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
5.9|7.1|6.5|492|VI Renal tumors|76418439|0-19|All Races|Male and Female|2002|5.9|7.0|6.4
5.5|6.6|6.0|458|VI(a) Nephroblastoma and other nonepithelial renal tumors|76418439|0-19|All Races|Male and Female|2002|5.5|6.6|6.0
0.3|0.6|0.4|33|VI(b) Renal carcinomas|76418439|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|76418439|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|129|VII Hepatic tumors|76418439|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.0|1.5|1.2|91|VII(a) Hepatoblastoma|76418439|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
0.3|0.7|0.5|37|VII(b) Hepatic carcinomas|76418439|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76418439|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.9|9.2|703|VIII Malignant bone tumors|76418439|0-19|All Races|Male and Female|2002|8.5|9.9|9.2
4.5|5.5|4.9|380|VIII(a) Osteosarcomas|76418439|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.6|0.5|36|VIII(b) Chondrosarcomas|76418439|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
2.7|3.5|3.1|235|VIII(c) Ewing tumor and related sarcomas of bone|76418439|0-19|All Races|Male and Female|2002|2.7|3.5|3.1
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|76418439|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|76418439|0-19|All Races|Male and Female|2002|~|~|~
10.5|12.0|11.2|860|X Germ cell, trophoblastic tumors & neoplasms of gonads|76418439|0-19|All Races|Male and Female|2002|10.5|12.0|11.3
1.4|2.0|1.7|129|X(a) Intracranial & intraspinal germ cell tumors|76418439|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|76418439|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.8|8.0|7.4|563|X(c) Malignant gonadal germ cell tumors|76418439|0-19|All Races|Male and Female|2002|6.8|8.0|7.4
0.2|0.5|0.3|23|X(d) Gonadal carcinomas|76418439|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|76418439|0-19|All Races|Male and Female|2002|0.2|0.4|0.3
16.5|18.4|17.4|1333|XI Other malignant epithelial neoplasms and malignant melanomas|76418439|0-19|All Races|Male and Female|2002|16.5|18.4|17.4
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|76418439|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.2|6.3|5.7|438|XI(b) Thyroid carcinomas|76418439|0-19|All Races|Male and Female|2002|5.2|6.3|5.7
0.5|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|76418439|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.1|7.3|6.7|509|XI(d) Malignant melanomas|76418439|0-19|All Races|Male and Female|2002|6.1|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|76418439|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|310|XI(f) Other and unspecified carcinomas|76418439|0-19|All Races|Male and Female|2002|3.6|4.5|4.1
0.6|1.0|0.8|59|XII Other and unspecified malignant neoplasms|76418439|0-19|All Races|Male and Female|2002|0.6|1.0|0.8
0.3|0.6|0.5|35|XII(a) Other specified malignant tumors|76418439|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
0.2|0.5|0.3|24|XII(b) Other unspecified malignant tumors|76418439|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
164.0|169.6|166.8|13308|All ICCC Groups Combined|79565248|0-19|All Races|Male and Female|2003|164.4|170.1|167.3
41.6|44.5|43.1|3425|I Leukemias, myeloproliferative & myelodysplastic diseases|79565248|0-19|All Races|Male and Female|2003|41.6|44.5|43.0
29.4|31.9|30.6|2430|I(a) Lymphoid leukemias|79565248|0-19|All Races|Male and Female|2003|29.3|31.8|30.5
7.1|8.3|7.7|617|I(b) Acute myeloid leukemias|79565248|0-19|All Races|Male and Female|2003|7.2|8.4|7.8
1.8|2.4|2.1|168|I(c) Chronic myeloproliferative diseases|79565248|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.4|1.9|1.6|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79565248|0-19|All Races|Male and Female|2003|1.4|1.9|1.6
0.8|1.2|1.0|80|I(e) Unspecified and other specified leukemias|79565248|0-19|All Races|Male and Female|2003|0.8|1.3|1.0
23.1|25.2|24.1|1924|II Lymphomas and reticuloendothelial neoplasms|79565248|0-19|All Races|Male and Female|2003|23.1|25.3|24.2
11.7|13.3|12.5|996|II(a) Hodgkin lymphomas|79565248|0-19|All Races|Male and Female|2003|11.8|13.3|12.5
7.4|8.7|8.0|640|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79565248|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
2.3|3.0|2.6|206|II(c) Burkitt lymphoma|79565248|0-19|All Races|Male and Female|2003|2.2|3.0|2.6
0.6|1.0|0.8|64|II(d) Miscellaneous lymphoreticular neoplasms|79565248|0-19|All Races|Male and Female|2003|0.6|1.0|0.8
0.1|0.4|0.2|18|II(e) Unspecified lymphomas|79565248|0-19|All Races|Male and Female|2003|0.1|0.4|0.2
28.6|31.0|29.8|2368|III CNS and misc intracranial and intraspinal neoplasms|79565248|0-19|All Races|Male and Female|2003|28.6|31.0|29.8
2.0|2.7|2.4|188|III(a) Ependymomas and choroid plexus tumor|79565248|0-19|All Races|Male and Female|2003|2.0|2.7|2.4
14.2|15.9|15.0|1193|III(b) Astrocytomas|79565248|0-19|All Races|Male and Female|2003|14.2|15.9|15.0
5.6|6.7|6.1|486|III(c) Intracranial and intraspinal embryonal tumors|79565248|0-19|All Races|Male and Female|2003|5.6|6.7|6.1
4.7|5.7|5.2|411|III(d) Other gliomas|79565248|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.6|1.0|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|79565248|0-19|All Races|Male and Female|2003|0.6|1.0|0.7
0.3|0.5|0.4|31|III(f) Unspecified intracranial and intraspinal neoplasms|79565248|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
7.5|8.7|8.1|650|IV Neuroblastoma and other peripheral nervous cell tumors|79565248|0-19|All Races|Male and Female|2003|7.6|8.8|8.2
7.3|8.6|7.9|637|IV(a) Neuroblastoma and ganglioneuroblastoma|79565248|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|79565248|0-19|All Races|Male and Female|2003|~|~|~
11.3|12.9|12.1|966|IX Soft tissue and other extraosseous sarcomas|79565248|0-19|All Races|Male and Female|2003|11.4|12.9|12.1
4.4|5.3|4.8|384|IX(a) Rhabdomyosarcomas|79565248|0-19|All Races|Male and Female|2003|4.4|5.3|4.8
1.2|1.7|1.4|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79565248|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|79565248|0-19|All Races|Male and Female|2003|~|~|~
4.1|5.1|4.6|368|IX(d) Other specified soft tissue sarcomas|79565248|0-19|All Races|Male and Female|2003|4.2|5.1|4.6
1.0|1.5|1.2|99|IX(e) Unspecified soft tissue sarcomas|79565248|0-19|All Races|Male and Female|2003|1.0|1.5|1.2
0.2|0.4|0.3|23|Not classified by ICCC|79565248|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.6|3.4|3.0|239|V Retinoblastoma|79565248|0-19|All Races|Male and Female|2003|2.6|3.4|3.0
6.1|7.2|6.7|530|VI Renal tumors|79565248|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.5|6.6|6.1|483|VI(a) Nephroblastoma and other nonepithelial renal tumors|79565248|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
0.4|0.7|0.5|43|VI(b) Renal carcinomas|79565248|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|79565248|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|172|VII Hepatic tumors|79565248|0-19|All Races|Male and Female|2003|1.9|2.5|2.2
1.3|1.8|1.5|123|VII(a) Hepatoblastoma|79565248|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|49|VII(b) Hepatic carcinomas|79565248|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79565248|0-19|All Races|Male and Female|2003|~|~|~
8.1|9.5|8.8|703|VIII Malignant bone tumors|79565248|0-19|All Races|Male and Female|2003|8.2|9.5|8.8
4.9|5.9|5.4|429|VIII(a) Osteosarcomas|79565248|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.2|20|VIII(b) Chondrosarcomas|79565248|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.3|3.0|2.6|210|VIII(c) Ewing tumor and related sarcomas of bone|79565248|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|27|VIII(d) Other specified malignant bone tumors|79565248|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|79565248|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.7|11.1|10.4|831|X Germ cell, trophoblastic tumors & neoplasms of gonads|79565248|0-19|All Races|Male and Female|2003|9.7|11.2|10.4
1.1|1.7|1.4|110|X(a) Intracranial & intraspinal germ cell tumors|79565248|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.8|1.5|118|X(b) Malignant extracranial & extragonadal germ cell tumors|79565248|0-19|All Races|Male and Female|2003|1.2|1.8|1.5
6.2|7.4|6.8|543|X(c) Malignant gonadal germ cell tumors|79565248|0-19|All Races|Male and Female|2003|6.3|7.4|6.8
0.2|0.5|0.4|29|X(d) Gonadal carcinomas|79565248|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|79565248|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.6|18.4|17.5|1399|XI Other malignant epithelial neoplasms and malignant melanomas|79565248|0-19|All Races|Male and Female|2003|16.7|18.5|17.6
0.2|0.4|0.3|20|XI(a) Adrenocortical carcinomas|79565248|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
5.6|6.7|6.1|492|XI(b) Thyroid carcinomas|79565248|0-19|All Races|Male and Female|2003|5.6|6.8|6.2
0.5|0.9|0.7|53|XI(c) Nasopharyngeal carcinomas|79565248|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.5|6.6|6.1|485|XI(d) Malignant melanomas|79565248|0-19|All Races|Male and Female|2003|5.6|6.7|6.1
~|~|~|~|XI(e) Skin carcinomas|79565248|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.3|341|XI(f) Other and unspecified carcinomas|79565248|0-19|All Races|Male and Female|2003|3.8|4.8|4.3
0.8|1.2|1.0|78|XII Other and unspecified malignant neoplasms|79565248|0-19|All Races|Male and Female|2003|0.8|1.2|1.0
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|79565248|0-19|All Races|Male and Female|2003|0.3|0.6|0.5
0.4|0.7|0.5|42|XII(b) Other unspecified malignant tumors|79565248|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
169.0|171.6|170.3|68127|All ICCC Groups Combined|397072513|0-19|All Races|Male and Female|2003-2007|170.3|172.9|171.6
44.0|45.3|44.6|17792|I Leukemias, myeloproliferative & myelodysplastic diseases|397072513|0-19|All Races|Male and Female|2003-2007|44.2|45.5|44.8
31.5|32.6|32.0|12743|I(a) Lymphoid leukemias|397072513|0-19|All Races|Male and Female|2003-2007|31.5|32.7|32.1
7.6|8.1|7.8|3143|I(b) Acute myeloid leukemias|397072513|0-19|All Races|Male and Female|2003-2007|7.6|8.2|7.9
1.9|2.2|2.1|824|I(c) Chronic myeloproliferative diseases|397072513|0-19|All Races|Male and Female|2003-2007|1.9|2.2|2.1
1.3|1.6|1.4|583|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|397072513|0-19|All Races|Male and Female|2003-2007|1.4|1.6|1.5
1.1|1.4|1.2|499|I(e) Unspecified and other specified leukemias|397072513|0-19|All Races|Male and Female|2003-2007|1.1|1.4|1.3
24.4|25.4|24.9|9944|II Lymphomas and reticuloendothelial neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|24.6|25.5|25.0
12.1|12.8|12.5|4999|II(a) Hodgkin lymphomas|397072513|0-19|All Races|Male and Female|2003-2007|12.2|12.9|12.6
8.3|8.9|8.6|3424|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|397072513|0-19|All Races|Male and Female|2003-2007|8.3|8.9|8.6
2.3|2.7|2.5|985|II(c) Burkitt lymphoma|397072513|0-19|All Races|Male and Female|2003-2007|2.3|2.6|2.5
0.9|1.1|1.0|401|II(d) Miscellaneous lymphoreticular neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|0.9|1.1|1.0
0.3|0.4|0.3|135|II(e) Unspecified lymphomas|397072513|0-19|All Races|Male and Female|2003-2007|0.3|0.4|0.3
29.6|30.7|30.1|11947|III CNS and misc intracranial and intraspinal neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|29.6|30.6|30.1
2.5|2.8|2.6|1047|III(a) Ependymomas and choroid plexus tumor|397072513|0-19|All Races|Male and Female|2003-2007|2.5|2.8|2.6
14.6|15.4|15.0|5957|III(b) Astrocytomas|397072513|0-19|All Races|Male and Female|2003-2007|14.6|15.4|15.0
6.0|6.5|6.2|2463|III(c) Intracranial and intraspinal embryonal tumors|397072513|0-19|All Races|Male and Female|2003-2007|6.0|6.5|6.2
4.9|5.3|5.1|2015|III(d) Other gliomas|397072513|0-19|All Races|Male and Female|2003-2007|4.9|5.3|5.1
0.6|0.7|0.7|264|III(e) Other specified intracranial & intraspinal neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|0.6|0.8|0.7
0.4|0.6|0.5|201|III(f) Unspecified intracranial and intraspinal neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|0.4|0.6|0.5
8.0|8.6|8.3|3371|IV Neuroblastoma and other peripheral nervous cell tumors|397072513|0-19|All Races|Male and Female|2003-2007|8.2|8.8|8.5
7.8|8.4|8.1|3289|IV(a) Neuroblastoma and ganglioneuroblastoma|397072513|0-19|All Races|Male and Female|2003-2007|8.0|8.6|8.3
0.2|0.3|0.2|82|IV(b) Other peripheral nervous cell tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.2|0.3|0.2
11.7|12.4|12.1|4823|IX Soft tissue and other extraosseous sarcomas|397072513|0-19|All Races|Male and Female|2003-2007|11.8|12.5|12.1
4.5|5.0|4.8|1891|IX(a) Rhabdomyosarcomas|397072513|0-19|All Races|Male and Female|2003-2007|4.6|5.0|4.8
1.2|1.5|1.3|541|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|397072513|0-19|All Races|Male and Female|2003-2007|1.3|1.5|1.4
0.0|0.1|0.0|16|IX(c) Kaposi sarcoma|397072513|0-19|All Races|Male and Female|2003-2007|0.0|0.1|0.0
4.6|5.0|4.8|1913|IX(d) Other specified soft tissue sarcomas|397072513|0-19|All Races|Male and Female|2003-2007|4.6|5.0|4.8
1.1|1.3|1.2|462|IX(e) Unspecified soft tissue sarcomas|397072513|0-19|All Races|Male and Female|2003-2007|1.1|1.3|1.2
0.3|0.4|0.3|125|Not classified by ICCC|397072513|0-19|All Races|Male and Female|2003-2007|0.3|0.4|0.3
2.8|3.2|3.0|1223|V Retinoblastoma|397072513|0-19|All Races|Male and Female|2003-2007|2.9|3.3|3.1
6.3|6.8|6.6|2640|VI Renal tumors|397072513|0-19|All Races|Male and Female|2003-2007|6.4|6.9|6.6
5.7|6.2|5.9|2382|VI(a) Nephroblastoma and other nonepithelial renal tumors|397072513|0-19|All Races|Male and Female|2003-2007|5.8|6.2|6.0
0.5|0.7|0.6|241|VI(b) Renal carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.5|0.7|0.6
0.0|0.1|0.0|17|VI(c) Unspecified malignant renal tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.0|0.1|0.0
2.1|2.4|2.2|898|VII Hepatic tumors|397072513|0-19|All Races|Male and Female|2003-2007|2.1|2.4|2.3
1.5|1.7|1.6|641|VII(a) Hepatoblastoma|397072513|0-19|All Races|Male and Female|2003-2007|1.5|1.7|1.6
0.5|0.7|0.6|243|VII(b) Hepatic carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|397072513|0-19|All Races|Male and Female|2003-2007|~|~|~
8.6|9.2|8.9|3556|VIII Malignant bone tumors|397072513|0-19|All Races|Male and Female|2003-2007|8.7|9.3|9.0
4.9|5.3|5.1|2035|VIII(a) Osteosarcomas|397072513|0-19|All Races|Male and Female|2003-2007|4.9|5.4|5.1
0.3|0.4|0.3|126|VIII(b) Chondrosarcomas|397072513|0-19|All Races|Male and Female|2003-2007|0.3|0.4|0.3
2.7|3.0|2.9|1143|VIII(c) Ewing tumor and related sarcomas of bone|397072513|0-19|All Races|Male and Female|2003-2007|2.7|3.1|2.9
0.4|0.5|0.4|168|VIII(d) Other specified malignant bone tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.4|0.5|0.4
0.2|0.3|0.2|84|VIII(e) Unspecified malignant bone tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.2|0.3|0.2
10.5|11.2|10.8|4381|X Germ cell, trophoblastic tumors & neoplasms of gonads|397072513|0-19|All Races|Male and Female|2003-2007|10.7|11.4|11.0
1.5|1.7|1.6|630|X(a) Intracranial & intraspinal germ cell tumors|397072513|0-19|All Races|Male and Female|2003-2007|1.5|1.7|1.6
1.3|1.6|1.4|587|X(b) Malignant extracranial & extragonadal germ cell tumors|397072513|0-19|All Races|Male and Female|2003-2007|1.4|1.6|1.5
6.9|7.4|7.1|2882|X(c) Malignant gonadal germ cell tumors|397072513|0-19|All Races|Male and Female|2003-2007|7.0|7.5|7.3
0.3|0.5|0.4|163|X(d) Gonadal carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.3|0.5|0.4
0.2|0.4|0.3|119|X(e) Other and unspecified malignant gonadal tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.2|0.4|0.3
17.2|18.0|17.6|7090|XI Other malignant epithelial neoplasms and malignant melanomas|397072513|0-19|All Races|Male and Female|2003-2007|17.4|18.3|17.9
0.2|0.2|0.2|80|XI(a) Adrenocortical carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.2|0.3|0.2
6.4|6.9|6.6|2671|XI(b) Thyroid carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|6.5|7.0|6.7
0.5|0.7|0.6|234|XI(c) Nasopharyngeal carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.5|0.7|0.6
5.7|6.2|6.0|2401|XI(d) Malignant melanomas|397072513|0-19|All Races|Male and Female|2003-2007|5.8|6.3|6.0
0.1|0.1|0.1|36|XI(e) Skin carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|0.1|0.1|0.1
4.0|4.4|4.1|1668|XI(f) Other and unspecified carcinomas|397072513|0-19|All Races|Male and Female|2003-2007|4.0|4.4|4.2
0.8|0.9|0.8|337|XII Other and unspecified malignant neoplasms|397072513|0-19|All Races|Male and Female|2003-2007|0.8|0.9|0.8
0.3|0.5|0.4|156|XII(a) Other specified malignant tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.3|0.5|0.4
0.4|0.5|0.5|181|XII(b) Other unspecified malignant tumors|397072513|0-19|All Races|Male and Female|2003-2007|0.4|0.5|0.5
170.1|175.8|172.9|14154|All ICCC Groups Combined|81414417|0-19|All Races|Male and Female|2004|171.0|176.7|173.9
44.1|47.0|45.5|3716|I Leukemias, myeloproliferative & myelodysplastic diseases|81414417|0-19|All Races|Male and Female|2004|44.2|47.1|45.6
31.5|34.0|32.7|2666|I(a) Lymphoid leukemias|81414417|0-19|All Races|Male and Female|2004|31.5|34.0|32.7
7.6|8.9|8.3|677|I(b) Acute myeloid leukemias|81414417|0-19|All Races|Male and Female|2004|7.7|9.0|8.3
1.6|2.3|1.9|158|I(c) Chronic myeloproliferative diseases|81414417|0-19|All Races|Male and Female|2004|1.6|2.3|1.9
1.1|1.6|1.3|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81414417|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.3|105|I(e) Unspecified and other specified leukemias|81414417|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
23.3|25.5|24.4|1995|II Lymphomas and reticuloendothelial neoplasms|81414417|0-19|All Races|Male and Female|2004|23.4|25.6|24.5
11.3|12.8|12.1|989|II(a) Hodgkin lymphomas|81414417|0-19|All Races|Male and Female|2004|11.4|12.9|12.1
7.9|9.2|8.6|699|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81414417|0-19|All Races|Male and Female|2004|8.0|9.2|8.6
2.0|2.7|2.3|190|II(c) Burkitt lymphoma|81414417|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.8|1.2|1.0|83|II(d) Miscellaneous lymphoreticular neoplasms|81414417|0-19|All Races|Male and Female|2004|0.8|1.3|1.0
0.3|0.6|0.4|34|II(e) Unspecified lymphomas|81414417|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
30.0|32.5|31.2|2540|III CNS and misc intracranial and intraspinal neoplasms|81414417|0-19|All Races|Male and Female|2004|30.0|32.4|31.2
2.4|3.1|2.8|225|III(a) Ependymomas and choroid plexus tumor|81414417|0-19|All Races|Male and Female|2004|2.4|3.1|2.8
14.9|16.6|15.7|1280|III(b) Astrocytomas|81414417|0-19|All Races|Male and Female|2004|14.9|16.6|15.7
6.0|7.1|6.5|529|III(c) Intracranial and intraspinal embryonal tumors|81414417|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|409|III(d) Other gliomas|81414417|0-19|All Races|Male and Female|2004|4.5|5.5|5.0
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|81414417|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|40|III(f) Unspecified intracranial and intraspinal neoplasms|81414417|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.7|9.0|8.3|690|IV Neuroblastoma and other peripheral nervous cell tumors|81414417|0-19|All Races|Male and Female|2004|7.9|9.1|8.5
7.4|8.7|8.0|668|IV(a) Neuroblastoma and ganglioneuroblastoma|81414417|0-19|All Races|Male and Female|2004|7.6|8.9|8.2
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|81414417|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.0|984|IX Soft tissue and other extraosseous sarcomas|81414417|0-19|All Races|Male and Female|2004|11.3|12.9|12.1
3.9|4.9|4.4|357|IX(a) Rhabdomyosarcomas|81414417|0-19|All Races|Male and Female|2004|3.9|4.9|4.4
1.1|1.6|1.3|110|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81414417|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81414417|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|415|IX(d) Other specified soft tissue sarcomas|81414417|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
1.0|1.5|1.2|99|IX(e) Unspecified soft tissue sarcomas|81414417|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.5|0.4|29|Not classified by ICCC|81414417|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
2.8|3.6|3.2|265|V Retinoblastoma|81414417|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
5.9|7.0|6.4|527|VI Renal tumors|81414417|0-19|All Races|Male and Female|2004|5.9|7.1|6.5
5.3|6.4|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81414417|0-19|All Races|Male and Female|2004|5.4|6.4|5.9
0.4|0.7|0.6|46|VI(b) Renal carcinomas|81414417|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81414417|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.7|2.4|197|VII Hepatic tumors|81414417|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.4|2.0|1.7|143|VII(a) Hepatoblastoma|81414417|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81414417|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81414417|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.0|738|VIII Malignant bone tumors|81414417|0-19|All Races|Male and Female|2004|8.4|9.7|9.1
4.7|5.7|5.2|422|VIII(a) Osteosarcomas|81414417|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81414417|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|222|VIII(c) Ewing tumor and related sarcomas of bone|81414417|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
0.3|0.7|0.5|39|VIII(d) Other specified malignant bone tumors|81414417|0-19|All Races|Male and Female|2004|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81414417|0-19|All Races|Male and Female|2004|~|~|~
10.5|12.0|11.2|926|X Germ cell, trophoblastic tumors & neoplasms of gonads|81414417|0-19|All Races|Male and Female|2004|10.7|12.1|11.4
1.5|2.1|1.8|149|X(a) Intracranial & intraspinal germ cell tumors|81414417|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81414417|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
6.8|8.0|7.4|608|X(c) Malignant gonadal germ cell tumors|81414417|0-19|All Races|Male and Female|2004|6.9|8.1|7.5
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81414417|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81414417|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
17.1|19.0|18.0|1480|XI Other malignant epithelial neoplasms and malignant melanomas|81414417|0-19|All Races|Male and Female|2004|17.3|19.1|18.2
0.1|0.3|0.2|18|XI(a) Adrenocortical carcinomas|81414417|0-19|All Races|Male and Female|2004|0.1|0.3|0.2
6.3|7.4|6.8|561|XI(b) Thyroid carcinomas|81414417|0-19|All Races|Male and Female|2004|6.3|7.5|6.9
0.4|0.8|0.6|47|XI(c) Nasopharyngeal carcinomas|81414417|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
6.0|7.1|6.5|533|XI(d) Malignant melanomas|81414417|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
~|~|~|~|XI(e) Skin carcinomas|81414417|0-19|All Races|Male and Female|2004|~|~|~
3.4|4.3|3.8|313|XI(f) Other and unspecified carcinomas|81414417|0-19|All Races|Male and Female|2004|3.4|4.3|3.8
0.6|1.0|0.8|67|XII Other and unspecified malignant neoplasms|81414417|0-19|All Races|Male and Female|2004|0.6|1.0|0.8
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|81414417|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
0.3|0.6|0.5|37|XII(b) Other unspecified malignant tumors|81414417|0-19|All Races|Male and Female|2004|0.3|0.6|0.5
167.4|173.1|170.2|14011|All ICCC Groups Combined|81624286|0-19|All Races|Male and Female|2005|168.8|174.5|171.7
42.3|45.2|43.7|3589|I Leukemias, myeloproliferative & myelodysplastic diseases|81624286|0-19|All Races|Male and Female|2005|42.5|45.4|44.0
30.4|32.8|31.6|2587|I(a) Lymphoid leukemias|81624286|0-19|All Races|Male and Female|2005|30.5|32.9|31.7
6.9|8.1|7.5|618|I(b) Acute myeloid leukemias|81624286|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.6|2.2|1.9|156|I(c) Chronic myeloproliferative diseases|81624286|0-19|All Races|Male and Female|2005|1.6|2.2|1.9
1.2|1.8|1.5|123|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81624286|0-19|All Races|Male and Female|2005|1.3|1.8|1.5
1.0|1.5|1.3|105|I(e) Unspecified and other specified leukemias|81624286|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.8|27.0|25.8|2126|II Lymphomas and reticuloendothelial neoplasms|81624286|0-19|All Races|Male and Female|2005|25.0|27.2|26.0
12.1|13.7|12.9|1065|II(a) Hodgkin lymphomas|81624286|0-19|All Races|Male and Female|2005|12.3|13.9|13.0
8.4|9.7|9.0|738|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81624286|0-19|All Races|Male and Female|2005|8.4|9.7|9.0
2.2|2.9|2.5|202|II(c) Burkitt lymphoma|81624286|0-19|All Races|Male and Female|2005|2.1|2.8|2.5
0.9|1.4|1.1|94|II(d) Miscellaneous lymphoreticular neoplasms|81624286|0-19|All Races|Male and Female|2005|0.9|1.4|1.2
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81624286|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
27.9|30.3|29.1|2369|III CNS and misc intracranial and intraspinal neoplasms|81624286|0-19|All Races|Male and Female|2005|27.9|30.2|29.0
2.5|3.2|2.9|234|III(a) Ependymomas and choroid plexus tumor|81624286|0-19|All Races|Male and Female|2005|2.5|3.3|2.9
13.8|15.5|14.6|1194|III(b) Astrocytomas|81624286|0-19|All Races|Male and Female|2005|13.8|15.5|14.6
5.3|6.3|5.8|471|III(c) Intracranial and intraspinal embryonal tumors|81624286|0-19|All Races|Male and Female|2005|5.3|6.3|5.8
4.2|5.2|4.7|380|III(d) Other gliomas|81624286|0-19|All Races|Male and Female|2005|4.2|5.1|4.7
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|81624286|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.7|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|81624286|0-19|All Races|Male and Female|2005|0.3|0.7|0.5
8.2|9.5|8.8|740|IV Neuroblastoma and other peripheral nervous cell tumors|81624286|0-19|All Races|Male and Female|2005|8.4|9.7|9.1
8.0|9.3|8.6|721|IV(a) Neuroblastoma and ganglioneuroblastoma|81624286|0-19|All Races|Male and Female|2005|8.2|9.5|8.8
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|81624286|0-19|All Races|Male and Female|2005|0.1|0.4|0.2
11.7|13.2|12.4|1020|IX Soft tissue and other extraosseous sarcomas|81624286|0-19|All Races|Male and Female|2005|11.7|13.3|12.5
4.5|5.5|5.0|407|IX(a) Rhabdomyosarcomas|81624286|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
1.2|1.7|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81624286|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81624286|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|405|IX(d) Other specified soft tissue sarcomas|81624286|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.3|1.1|89|IX(e) Unspecified soft tissue sarcomas|81624286|0-19|All Races|Male and Female|2005|0.9|1.3|1.1
0.2|0.5|0.3|28|Not classified by ICCC|81624286|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
2.5|3.2|2.8|237|V Retinoblastoma|81624286|0-19|All Races|Male and Female|2005|2.5|3.3|2.9
6.0|7.1|6.6|542|VI Renal tumors|81624286|0-19|All Races|Male and Female|2005|6.1|7.2|6.6
5.4|6.4|5.9|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|81624286|0-19|All Races|Male and Female|2005|5.4|6.5|6.0
0.5|0.8|0.6|51|VI(b) Renal carcinomas|81624286|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81624286|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|166|VII Hepatic tumors|81624286|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.1|1.6|1.4|115|VII(a) Hepatoblastoma|81624286|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81624286|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81624286|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.8|724|VIII Malignant bone tumors|81624286|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
4.6|5.5|5.0|412|VIII(a) Osteosarcomas|81624286|0-19|All Races|Male and Female|2005|4.6|5.6|5.0
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81624286|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|3.0|241|VIII(c) Ewing tumor and related sarcomas of bone|81624286|0-19|All Races|Male and Female|2005|2.6|3.3|3.0
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|81624286|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81624286|0-19|All Races|Male and Female|2005|~|~|~
10.7|12.2|11.4|949|X Germ cell, trophoblastic tumors & neoplasms of gonads|81624286|0-19|All Races|Male and Female|2005|10.9|12.4|11.6
1.3|1.8|1.5|127|X(a) Intracranial & intraspinal germ cell tumors|81624286|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.3|1.9|1.6|132|X(b) Malignant extracranial & extragonadal germ cell tumors|81624286|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
7.0|8.2|7.6|632|X(c) Malignant gonadal germ cell tumors|81624286|0-19|All Races|Male and Female|2005|7.2|8.4|7.7
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|81624286|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81624286|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.6|18.5|17.5|1451|XI Other malignant epithelial neoplasms and malignant melanomas|81624286|0-19|All Races|Male and Female|2005|16.9|18.7|17.8
~|~|~|~|XI(a) Adrenocortical carcinomas|81624286|0-19|All Races|Male and Female|2005|~|~|~
5.6|6.6|6.1|503|XI(b) Thyroid carcinomas|81624286|0-19|All Races|Male and Female|2005|5.6|6.7|6.2
0.3|0.6|0.4|33|XI(c) Nasopharyngeal carcinomas|81624286|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.6|543|XI(d) Malignant melanomas|81624286|0-19|All Races|Male and Female|2005|6.1|7.2|6.7
~|~|~|~|XI(e) Skin carcinomas|81624286|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.3|353|XI(f) Other and unspecified carcinomas|81624286|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.8|70|XII Other and unspecified malignant neoplasms|81624286|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|81624286|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|81624286|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
166.8|172.4|169.6|14020|All ICCC Groups Combined|81899061|0-19|All Races|Male and Female|2006|168.4|174.0|171.2
44.1|47.1|45.6|3758|I Leukemias, myeloproliferative & myelodysplastic diseases|81899061|0-19|All Races|Male and Female|2006|44.4|47.4|45.9
31.3|33.8|32.5|2674|I(a) Lymphoid leukemias|81899061|0-19|All Races|Male and Female|2006|31.4|33.9|32.6
7.4|8.6|8.0|663|I(b) Acute myeloid leukemias|81899061|0-19|All Races|Male and Female|2006|7.5|8.7|8.1
1.8|2.4|2.1|174|I(c) Chronic myeloproliferative diseases|81899061|0-19|All Races|Male and Female|2006|1.8|2.5|2.1
1.3|1.9|1.6|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81899061|0-19|All Races|Male and Female|2006|1.3|1.9|1.6
1.2|1.7|1.4|117|I(e) Unspecified and other specified leukemias|81899061|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
23.9|26.1|25.0|2060|II Lymphomas and reticuloendothelial neoplasms|81899061|0-19|All Races|Male and Female|2006|24.1|26.3|25.2
11.9|13.4|12.6|1048|II(a) Hodgkin lymphomas|81899061|0-19|All Races|Male and Female|2006|12.0|13.6|12.8
8.0|9.2|8.6|706|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81899061|0-19|All Races|Male and Female|2006|8.0|9.3|8.6
2.1|2.8|2.4|195|II(c) Burkitt lymphoma|81899061|0-19|All Races|Male and Female|2006|2.1|2.7|2.4
0.9|1.3|1.1|89|II(d) Miscellaneous lymphoreticular neoplasms|81899061|0-19|All Races|Male and Female|2006|0.9|1.3|1.1
0.2|0.4|0.3|22|II(e) Unspecified lymphomas|81899061|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
28.7|31.0|29.8|2445|III CNS and misc intracranial and intraspinal neoplasms|81899061|0-19|All Races|Male and Female|2006|28.7|31.1|29.9
2.4|3.2|2.8|229|III(a) Ependymomas and choroid plexus tumor|81899061|0-19|All Races|Male and Female|2006|2.4|3.2|2.8
13.8|15.5|14.6|1196|III(b) Astrocytomas|81899061|0-19|All Races|Male and Female|2006|13.8|15.5|14.6
5.7|6.8|6.2|512|III(c) Intracranial and intraspinal embryonal tumors|81899061|0-19|All Races|Male and Female|2006|5.7|6.8|6.3
4.6|5.6|5.1|411|III(d) Other gliomas|81899061|0-19|All Races|Male and Female|2006|4.5|5.5|5.0
0.4|0.7|0.6|46|III(e) Other specified intracranial & intraspinal neoplasms|81899061|0-19|All Races|Male and Female|2006|0.4|0.7|0.6
0.5|0.8|0.6|51|III(f) Unspecified intracranial and intraspinal neoplasms|81899061|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.0|8.2|7.6|637|IV Neuroblastoma and other peripheral nervous cell tumors|81899061|0-19|All Races|Male and Female|2006|7.2|8.4|7.8
6.9|8.0|7.4|625|IV(a) Neuroblastoma and ganglioneuroblastoma|81899061|0-19|All Races|Male and Female|2006|7.0|8.3|7.6
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81899061|0-19|All Races|Male and Female|2006|~|~|~
10.9|12.4|11.6|958|IX Soft tissue and other extraosseous sarcomas|81899061|0-19|All Races|Male and Female|2006|11.0|12.5|11.7
4.1|5.1|4.6|375|IX(a) Rhabdomyosarcomas|81899061|0-19|All Races|Male and Female|2006|4.1|5.1|4.6
1.1|1.6|1.3|108|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81899061|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|81899061|0-19|All Races|Male and Female|2006|~|~|~
4.1|5.0|4.5|372|IX(d) Other specified soft tissue sarcomas|81899061|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.0|1.5|1.2|100|IX(e) Unspecified soft tissue sarcomas|81899061|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.5|0.3|27|Not classified by ICCC|81899061|0-19|All Races|Male and Female|2006|0.2|0.5|0.3
2.6|3.3|2.9|250|V Retinoblastoma|81899061|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.0|7.1|6.6|546|VI Renal tumors|81899061|0-19|All Races|Male and Female|2006|6.1|7.3|6.7
5.3|6.4|5.8|485|VI(a) Nephroblastoma and other nonepithelial renal tumors|81899061|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|55|VI(b) Renal carcinomas|81899061|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|81899061|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.6|2.3|193|VII Hepatic tumors|81899061|0-19|All Races|Male and Female|2006|2.0|2.7|2.4
1.3|1.9|1.6|135|VII(a) Hepatoblastoma|81899061|0-19|All Races|Male and Female|2006|1.4|2.0|1.6
0.5|0.8|0.6|51|VII(b) Hepatic carcinomas|81899061|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81899061|0-19|All Races|Male and Female|2006|~|~|~
8.7|10.0|9.4|767|VIII Malignant bone tumors|81899061|0-19|All Races|Male and Female|2006|8.7|10.1|9.4
4.9|6.0|5.4|446|VIII(a) Osteosarcomas|81899061|0-19|All Races|Male and Female|2006|5.0|6.0|5.4
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|81899061|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.6|3.4|3.0|246|VIII(c) Ewing tumor and related sarcomas of bone|81899061|0-19|All Races|Male and Female|2006|2.6|3.4|3.0
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|81899061|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|81899061|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
9.5|10.9|10.2|852|X Germ cell, trophoblastic tumors & neoplasms of gonads|81899061|0-19|All Races|Male and Female|2006|9.7|11.1|10.4
1.2|1.8|1.5|122|X(a) Intracranial & intraspinal germ cell tumors|81899061|0-19|All Races|Male and Female|2006|1.2|1.8|1.5
1.2|1.8|1.5|126|X(b) Malignant extracranial & extragonadal germ cell tumors|81899061|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
5.9|7.0|6.4|537|X(c) Malignant gonadal germ cell tumors|81899061|0-19|All Races|Male and Female|2006|6.0|7.1|6.6
0.4|0.7|0.5|41|X(d) Gonadal carcinomas|81899061|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|26|X(e) Other and unspecified malignant gonadal tumors|81899061|0-19|All Races|Male and Female|2006|0.2|0.5|0.3
16.5|18.4|17.4|1451|XI Other malignant epithelial neoplasms and malignant melanomas|81899061|0-19|All Races|Male and Female|2006|16.8|18.7|17.7
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|81899061|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.2|7.3|6.8|563|XI(b) Thyroid carcinomas|81899061|0-19|All Races|Male and Female|2006|6.3|7.5|6.9
0.5|0.8|0.7|54|XI(c) Nasopharyngeal carcinomas|81899061|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
5.1|6.1|5.6|464|XI(d) Malignant melanomas|81899061|0-19|All Races|Male and Female|2006|5.2|6.2|5.7
~|~|~|~|XI(e) Skin carcinomas|81899061|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.7|4.2|349|XI(f) Other and unspecified carcinomas|81899061|0-19|All Races|Male and Female|2006|3.8|4.7|4.3
0.7|1.1|0.9|76|XII Other and unspecified malignant neoplasms|81899061|0-19|All Races|Male and Female|2006|0.7|1.2|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|81899061|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.6|0.4|35|XII(b) Other unspecified malignant tumors|81899061|0-19|All Races|Male and Female|2006|0.3|0.6|0.4
168.3|173.9|171.1|14119|All ICCC Groups Combined|81590953|0-19|All Races|Male and Female|2007|170.2|175.9|173.0
43.8|46.7|45.2|3719|I Leukemias, myeloproliferative & myelodysplastic diseases|81590953|0-19|All Races|Male and Female|2007|44.1|47.1|45.6
31.5|34.0|32.8|2690|I(a) Lymphoid leukemias|81590953|0-19|All Races|Male and Female|2007|31.7|34.2|33.0
7.1|8.3|7.7|634|I(b) Acute myeloid leukemias|81590953|0-19|All Races|Male and Female|2007|7.2|8.4|7.8
1.9|2.6|2.2|186|I(c) Chronic myeloproliferative diseases|81590953|0-19|All Races|Male and Female|2007|2.0|2.6|2.3
1.1|1.6|1.3|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81590953|0-19|All Races|Male and Female|2007|1.1|1.7|1.4
1.0|1.4|1.2|97|I(e) Unspecified and other specified leukemias|81590953|0-19|All Races|Male and Female|2007|1.0|1.5|1.2
23.6|25.8|24.7|2027|II Lymphomas and reticuloendothelial neoplasms|81590953|0-19|All Races|Male and Female|2007|23.8|25.9|24.8
11.4|12.9|12.1|1002|II(a) Hodgkin lymphomas|81590953|0-19|All Races|Male and Female|2007|11.5|13.1|12.3
7.9|9.2|8.6|699|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81590953|0-19|All Races|Male and Female|2007|7.9|9.2|8.6
2.3|3.0|2.6|210|II(c) Burkitt lymphoma|81590953|0-19|All Races|Male and Female|2007|2.2|2.9|2.6
0.7|1.2|0.9|79|II(d) Miscellaneous lymphoreticular neoplasms|81590953|0-19|All Races|Male and Female|2007|0.8|1.2|1.0
0.3|0.6|0.5|37|II(e) Unspecified lymphomas|81590953|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
29.0|31.4|30.2|2467|III CNS and misc intracranial and intraspinal neoplasms|81590953|0-19|All Races|Male and Female|2007|29.1|31.5|30.2
2.1|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|81590953|0-19|All Races|Male and Female|2007|2.1|2.8|2.4
14.1|15.7|14.9|1213|III(b) Astrocytomas|81590953|0-19|All Races|Male and Female|2007|14.0|15.7|14.9
5.8|6.9|6.4|520|III(c) Intracranial and intraspinal embryonal tumors|81590953|0-19|All Races|Male and Female|2007|5.8|6.9|6.4
4.9|5.9|5.4|438|III(d) Other gliomas|81590953|0-19|All Races|Male and Female|2007|4.9|5.9|5.4
0.5|0.9|0.7|58|III(e) Other specified intracranial & intraspinal neoplasms|81590953|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.4|0.7|0.5|42|III(f) Unspecified intracranial and intraspinal neoplasms|81590953|0-19|All Races|Male and Female|2007|0.4|0.7|0.5
7.9|9.2|8.5|722|IV Neuroblastoma and other peripheral nervous cell tumors|81590953|0-19|All Races|Male and Female|2007|8.2|9.5|8.8
7.7|9.0|8.3|706|IV(a) Neuroblastoma and ganglioneuroblastoma|81590953|0-19|All Races|Male and Female|2007|8.0|9.3|8.7
0.1|0.3|0.2|16|IV(b) Other peripheral nervous cell tumors|81590953|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
11.5|13.0|12.2|1008|IX Soft tissue and other extraosseous sarcomas|81590953|0-19|All Races|Male and Female|2007|11.6|13.1|12.4
4.6|5.6|5.1|417|IX(a) Rhabdomyosarcomas|81590953|0-19|All Races|Male and Female|2007|4.6|5.6|5.1
1.1|1.6|1.3|107|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81590953|0-19|All Races|Male and Female|2007|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|81590953|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.2|4.7|389|IX(d) Other specified soft tissue sarcomas|81590953|0-19|All Races|Male and Female|2007|4.3|5.3|4.8
0.9|1.4|1.1|92|IX(e) Unspecified soft tissue sarcomas|81590953|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.2|0.4|0.3|22|Not classified by ICCC|81590953|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
2.7|3.4|3.0|259|V Retinoblastoma|81590953|0-19|All Races|Male and Female|2007|2.8|3.6|3.2
6.1|7.3|6.7|555|VI Renal tumors|81590953|0-19|All Races|Male and Female|2007|6.2|7.4|6.8
5.5|6.5|6.0|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|81590953|0-19|All Races|Male and Female|2007|5.6|6.7|6.1
0.5|0.9|0.7|54|VI(b) Renal carcinomas|81590953|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|81590953|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.6|2.3|193|VII Hepatic tumors|81590953|0-19|All Races|Male and Female|2007|2.0|2.7|2.4
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|81590953|0-19|All Races|Male and Female|2007|1.5|2.1|1.7
0.4|0.8|0.6|50|VII(b) Hepatic carcinomas|81590953|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81590953|0-19|All Races|Male and Female|2007|~|~|~
8.0|9.3|8.6|703|VIII Malignant bone tumors|81590953|0-19|All Races|Male and Female|2007|8.0|9.3|8.6
4.1|5.1|4.6|374|VIII(a) Osteosarcomas|81590953|0-19|All Races|Male and Female|2007|4.1|5.1|4.6
0.2|0.5|0.4|29|VIII(b) Chondrosarcomas|81590953|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
2.7|3.5|3.1|250|VIII(c) Ewing tumor and related sarcomas of bone|81590953|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.2|0.5|0.3|26|VIII(d) Other specified malignant bone tumors|81590953|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
0.2|0.4|0.3|24|VIII(e) Unspecified malignant bone tumors|81590953|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.3|11.8|11.0|921|X Germ cell, trophoblastic tumors & neoplasms of gonads|81590953|0-19|All Races|Male and Female|2007|10.6|12.0|11.3
1.4|1.9|1.6|133|X(a) Intracranial & intraspinal germ cell tumors|81590953|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.6|1.3|113|X(b) Malignant extracranial & extragonadal germ cell tumors|81590953|0-19|All Races|Male and Female|2007|1.1|1.7|1.4
6.9|8.1|7.5|629|X(c) Malignant gonadal germ cell tumors|81590953|0-19|All Races|Male and Female|2007|7.1|8.3|7.7
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|81590953|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.1|0.3|0.2|16|X(e) Other and unspecified malignant gonadal tumors|81590953|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
16.7|18.5|17.6|1463|XI Other malignant epithelial neoplasms and malignant melanomas|81590953|0-19|All Races|Male and Female|2007|17.0|18.9|17.9
~|~|~|~|XI(a) Adrenocortical carcinomas|81590953|0-19|All Races|Male and Female|2007|~|~|~
6.6|7.7|7.1|595|XI(b) Thyroid carcinomas|81590953|0-19|All Races|Male and Female|2007|6.7|7.9|7.3
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|81590953|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
5.0|6.0|5.5|455|XI(d) Malignant melanomas|81590953|0-19|All Races|Male and Female|2007|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|81590953|0-19|All Races|Male and Female|2007|~|~|~
3.6|4.5|4.1|337|XI(f) Other and unspecified carcinomas|81590953|0-19|All Races|Male and Female|2007|3.7|4.6|4.1
0.5|0.9|0.7|60|XII Other and unspecified malignant neoplasms|81590953|0-19|All Races|Male and Female|2007|0.6|0.9|0.7
0.2|0.5|0.3|28|XII(a) Other specified malignant tumors|81590953|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|81590953|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
